| 1 |
Song J, Wang M, Du Y, Wan B, Zhang A, Zhang Y, Zhuang G, Ji P, Wu Y, Zhang G. Identification of a linear B-cell epitope on the African swine fever virus CD2v protein. Int J Biol Macromol 2023;232:123264. [PMID: 36706875 DOI: 10.1016/j.ijbiomac.2023.123264] [Reference Citation Analysis]
|
| 2 |
Stoler-Barak L, Harris E, Peres A, Hezroni H, Kuka M, Di Lucia P, Grenov A, Gurwicz N, Kupervaser M, Yip BH, Iannacone M, Yaari G, Crispino JD, Shulman Z. B cell class switch recombination is regulated by DYRK1A through MSH6 phosphorylation. Nat Commun 2023;14:1462. [PMID: 36927854 DOI: 10.1038/s41467-023-37205-5] [Reference Citation Analysis]
|
| 3 |
Thulasi Raman SN, Zetner A, Hashem A, Patel D, Wu J, Gravel C, Gao J, Zhang W, Pfeifle A, Tamming L, Parikh K, Cao J, Tam R, Safronetz D, Chen W, Johnston MJW, Wang L, Sauve S, Rosu-Myles M, Domselaar GV, Li X. Bivalent vaccines effectively protect mice against Influenza A and Respiratory Syncytial Viruses. Emerg Microbes Infect 2023;:2192821. [PMID: 36927227 DOI: 10.1080/22221751.2023.2192821] [Reference Citation Analysis]
|
| 4 |
Laumont CM, Nelson BH. B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity. Cancer Cell 2023;41:466-89. [PMID: 36917951 DOI: 10.1016/j.ccell.2023.02.017] [Reference Citation Analysis]
|
| 5 |
Loos C, Coccia M, Didierlaurent AM, Essaghir A, Fallon JK, Lauffenburger D, Luedemann C, Michell A, van der Most R, Zhu AL, Alter G, Burny W. Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design. NPJ Vaccines 2023;8:34. [PMID: 36890168 DOI: 10.1038/s41541-023-00613-1] [Reference Citation Analysis]
|
| 6 |
Schnittman SR, Jung W, Fitch KV, Zanni MV, McCallum S, Lee JS, Shin S, Davis BJ, Fulda ES, Diggs MR, Giguel F, Chinchay R, Sheth AN, Fichtenbaum CJ, Malvestutto C, Aberg JA, Currier J, Lauffenburger DA, Douglas PS, Ribaudo HJ, Alter G, Grinspoon SK. Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV. JCI Insight 2023;8:e166848. [PMID: 36805331 DOI: 10.1172/jci.insight.166848] [Reference Citation Analysis]
|
| 7 |
Kharga K, Kumar L, Patel SKS. Recent Advances in Monoclonal Antibody-Based Approaches in the Management of Bacterial Sepsis. Biomedicines 2023;11:765. [DOI: 10.3390/biomedicines11030765] [Reference Citation Analysis]
|
| 8 |
Jugler C, Sun H, Nguyen K, Palt R, Felder M, Steinkellner H, Chen Q. A novel plant-made monoclonal antibody enhances the synergetic potency of an antibody cocktail against the SARS-CoV-2 Omicron variant. Plant Biotechnol J 2023;21:549-59. [PMID: 36403203 DOI: 10.1111/pbi.13970] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Luo S, Su Y, Wu Z, Su C, Peng J, Ma J. Rotamer Density Estimator is an Unsupervised Learner of the Effect of Mutations on Protein-Protein Interaction.. [DOI: 10.1101/2023.02.28.530137] [Reference Citation Analysis]
|
| 10 |
Hoehener C, Engeroff P. Hinge region modification for the engineering of antibody function. Allergy 2023. [PMID: 36805570 DOI: 10.1111/all.15684] [Reference Citation Analysis]
|
| 11 |
Toshkova N, Zhelyazkova V, Justesen S, Dimitrov JD. Conservative pattern of interaction of bat and human IgG antibodies with FcRn. Dev Comp Immunol 2023;139:104579. [PMID: 36272453 DOI: 10.1016/j.dci.2022.104579] [Reference Citation Analysis]
|
| 12 |
Zinn S, Vazquez-Lombardi R, Zimmermann C, Sapra P, Jermutus L, Christ D. Advances in antibody-based therapy in oncology. Nat Cancer 2023;4:165-80. [PMID: 36806801 DOI: 10.1038/s43018-023-00516-z] [Reference Citation Analysis]
|
| 13 |
Batty CJ, Lifshits LM, Hendy DA, Eckshtain-Levi M, Ontiveros-Padilla LA, Carlock MA, Ross TM, Bachelder EM, Ainslie KM. Vinyl Sulfone-functionalized Acetalated Dextran Microparticles as a Subunit Broadly Acting Influenza Vaccine. AAPS J 2023;25:22. [PMID: 36720729 DOI: 10.1208/s12248-023-00786-6] [Reference Citation Analysis]
|
| 14 |
Wang D, Ye F, Hao Z. On Pre-trained Language Models for Antibody.. [DOI: 10.1101/2023.01.29.525793] [Reference Citation Analysis]
|
| 15 |
Helmy YA, Taha-Abdelaziz K, Hawwas HAE, Ghosh S, AlKafaas SS, Moawad MMM, Saied EM, Kassem II, Mawad AMM. Antimicrobial Resistance and Recent Alternatives to Antibiotics for the Control of Bacterial Pathogens with an Emphasis on Foodborne Pathogens. Antibiotics (Basel) 2023;12. [PMID: 36830185 DOI: 10.3390/antibiotics12020274] [Reference Citation Analysis]
|
| 16 |
Abebe EC, Dejenie TA. Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications. Front Immunol 2023;14:1055457. [PMID: 36742320 DOI: 10.3389/fimmu.2023.1055457] [Reference Citation Analysis]
|
| 17 |
Pedraza-Sánchez S, Cruz-González A, Palmeros-Rojas O, Gálvez-Romero JL, Bellanti JA, Torres M. Polyvalent human immunoglobulin for infectious diseases: Potential to circumvent antimicrobial resistance. Front Immunol 2022;13:987231. [PMID: 36713426 DOI: 10.3389/fimmu.2022.987231] [Reference Citation Analysis]
|
| 18 |
Rais M, Abdelaal H, Reese VA, Ferede D, Larsen SE, Pecor T, Erasmus JH, Archer J, Khandhar AP, Cooper SK, Podell BK, Reed SG, Coler RN, Baldwin SL. Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen. Tuberculosis (Edinb) 2023;138:102302. [PMID: 36586154 DOI: 10.1016/j.tube.2022.102302] [Reference Citation Analysis]
|
| 19 |
Rahman MM, Masum MHU, Talukder A, Akter R. An in silico reverse vaccinology approach to design a novel multiepitope peptide vaccine for non-small cell lung cancers. Informatics in Medicine Unlocked 2023. [DOI: 10.1016/j.imu.2023.101169] [Reference Citation Analysis]
|
| 20 |
James LK. B cells defined by immunoglobulin isotypes. Clin Exp Immunol 2022;210:230-9. [PMID: 36197112 DOI: 10.1093/cei/uxac091] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Ullah I, Beaudoin-Bussières G, Symmes K, Cloutier M, Ducas E, Tauzin A, Laumaea A, Grunst MW, Dionne K, Richard J, Bégin P, Mothes W, Kumar P, Bazin R, Finzi A, Uchil PD. The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice. Cell Rep Med 2023;4:100893. [PMID: 36584683 DOI: 10.1016/j.xcrm.2022.100893] [Reference Citation Analysis]
|
| 22 |
Bartsch YC, Cizmeci D, Kang J, Zohar T, Periasamy S, Mehta N, Tolboom J, Van der Fits L, Sadoff J, Comeaux C, Callendret B, Bukreyev A, Lauffenburger DA, Bastian AR, Alter G. Antibody effector functions are associated with protection from respiratory syncytial virus. Cell 2022;185:4873-4886.e10. [PMID: 36513064 DOI: 10.1016/j.cell.2022.11.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, Yona Tugg, Art Marzok, Matthew S. Miller. Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection. Nat Rev Immunol 2022. [PMID: 36536068 DOI: 10.1038/s41577-022-00813-1] [Reference Citation Analysis]
|
| 24 |
Waldran MJ, Wegman AD, Bahr LE, Currier JR, Waickman AT. Soluble NS1 antagonizes IgG- and IgA-mediated monocytic phagocytosis of DENV infected cells.. [DOI: 10.1101/2022.12.17.520876] [Reference Citation Analysis]
|
| 25 |
Bahnan W, Happonen L, Khakzad H, Kumra Ahnlide V, de Neergaard T, Wrighton S, André O, Bratanis E, Tang D, Hellmark T, Björck L, Shannon O, Malmström L, Malmström J, Nordenfelt P. A human monoclonal antibody bivalently binding two different epitopes in streptococcal M protein mediates immune function. EMBO Mol Med 2023;15:e16208. [PMID: 36507602 DOI: 10.15252/emmm.202216208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
An B, Guo Z, Wang J, Zhang C, Zhang G, Yan L. Derivation and external validation of dendritic cell-related gene signatures for predicting prognosis and immunotherapy efficacy in bladder urothelial carcinoma. Front Immunol 2022;13:1080947. [PMID: 36578478 DOI: 10.3389/fimmu.2022.1080947] [Reference Citation Analysis]
|
| 27 |
Jurenka J, Nagyová A, Dababseh M, Mihalov P, Stankovič I, Boža V, Kravec M, Palkovič M, Čaprnda M, Sabaka P. Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study. Infect Dis Rep 2022;14:1004-16. [PMID: 36547246 DOI: 10.3390/idr14060100] [Reference Citation Analysis]
|
| 28 |
Flynn JL, Chan J. Immune cell interactions in tuberculosis. Cell 2022;185:4682-702. [PMID: 36493751 DOI: 10.1016/j.cell.2022.10.025] [Reference Citation Analysis]
|
| 29 |
Kim AS, Diamond MS. A molecular understanding of alphavirus entry and antibody protection. Nat Rev Microbiol 2022;:1-12. [PMID: 36474012 DOI: 10.1038/s41579-022-00825-7] [Reference Citation Analysis]
|
| 30 |
Faber E, Tshilwane SI, Van Kleef M, Pretorius A. The impact of Escherichia coli contamination products present in recombinant African horse sickness virus serotype 4 proteins on the innate and humoral immune responses. Molecular Immunology 2022;152:1-13. [DOI: 10.1016/j.molimm.2022.09.013] [Reference Citation Analysis]
|
| 31 |
Blanc P, Liu Y, Reveneau N, Cavell B, Gorringe A, Renauld-Mongénie G. The role of bactericidal and opsonic activity in immunity against Bordetella pertussis. Expert Rev Vaccines 2022;21:1727-38. [PMID: 36369768 DOI: 10.1080/14760584.2022.2137145] [Reference Citation Analysis]
|
| 32 |
Otsubo R, Yasui T. Monoclonal antibody therapeutics for infectious diseases: Beyond normal human immunoglobulin. Pharmacol Ther 2022;240:108233. [PMID: 35738431 DOI: 10.1016/j.pharmthera.2022.108233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 33 |
Cross RM, Wiethoff CM, Brown-augsburger P, Berens S, Blackbourne J, Liu L, Wu X, Tetreault J, Dodd C, Sina R, Witcher DR, Newcomb D, Frost D, Wilcox A, Borisevich V, Agans KN, Woolsey C, Prasad AN, Deer DJ, Geisbert JB, Dobias NS, Fenton KA, Strifler B, Ebert P, Higgs R, Beall A, Chanda S, Riva L, Yin X, Geisbert TW. The therapeutic monoclonal antibody bamlanivimab does not enhance SARS‑CoV-2 infection by FcR-mediated mechanisms.. [DOI: 10.21203/rs.3.rs-2285240/v1] [Reference Citation Analysis]
|
| 34 |
Wolf C, Köppert S, Becza N, Kuerten S, Kirchenbaum GA, Lehmann PV. Antibody Levels Poorly Reflect on the Frequency of Memory B Cells Generated following SARS-CoV-2, Seasonal Influenza, or EBV Infection. Cells 2022;11. [PMID: 36429090 DOI: 10.3390/cells11223662] [Reference Citation Analysis]
|
| 35 |
Bruel T, Stéfic K, Nguyen Y, Toniutti D, Staropoli I, Porrot F, Guivel-Benhassine F, Bolland WH, Planas D, Hadjadj J, Handala L, Planchais C, Prot M, Simon-Lorière E, André E, Baele G, Cuypers L, Mouthon L, Mouquet H, Buchrieser J, Sève A, Prazuck T, Maes P, Terrier B, Hocqueloux L, Schwartz O. Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies. Cell Rep Med 2022;3:100850. [PMID: 36450283 DOI: 10.1016/j.xcrm.2022.100850] [Reference Citation Analysis]
|
| 36 |
Minott JA, van Vloten JP, Yates JGE, Chan L, Wood GA, Viloria-petit AM, Karimi K, Petrik JJ, Wootton SK, Bridle BW. Multiplex flow cytometry-based assay for quantifying tumor- and virus-associated antibodies induced by immunotherapies. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1038340] [Reference Citation Analysis]
|
| 37 |
Bharadwaj P, Shrestha S, Pongracz T, Concetta C, Sharma S, Le Moine A, de Haan N, Murakami N, Riella LV, Holovska V, Wuhrer M, Marchant A, Ackerman ME. Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation. Cell Rep Med 2022;3:100818. [PMID: 36384101 DOI: 10.1016/j.xcrm.2022.100818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 38 |
Ma C, Liu H, Yang S, Li H, Liao X, Kang Y. The emerging roles and therapeutic potential of B cells in sepsis. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1034667] [Reference Citation Analysis]
|
| 39 |
Bates TA, Lu P, Kang YJ, Schoen D, Thornton M, McBride SK, Park C, Kim D, Messer WB, Curlin ME, Tafesse FG, Lu LL. BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age. Cell Rep 2022;41:111544. [PMID: 36252569 DOI: 10.1016/j.celrep.2022.111544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Vo HTM, Upasani V, Auerswald H, Lay S, Sann S, Vanderlinden A, Ken S, Sorn S, Ly S, Duong V, Dussart P, Cantaert T. Temporal patterns of functional anti-dengue antibodies in dengue infected individuals with different disease outcome or infection history. Sci Rep 2022;12:17863. [PMID: 36284116 DOI: 10.1038/s41598-022-21722-2] [Reference Citation Analysis]
|
| 41 |
Mojtaba Porbahaie, Huub F. J. Savelkoul, Cornelis A. M. de Haan, Malgorzata Teodorowicz, R. J. Joost van Neerven. Direct Binding of Bovine IgG-Containing Immune Complexes to Human Monocytes and Their Putative Role in Innate Immune Training. Nutrients 2022;14:4452. [PMID: 36364714 DOI: 10.3390/nu14214452] [Reference Citation Analysis]
|
| 42 |
Muslimov IA, Berardi V, Stephenson S, Ginzler EM, Hanly JG, Tiedge H. Autoimmune RNA dysregulation and seizures: therapeutic prospects in neuropsychiatric lupus. Life Sci Alliance 2022;5. [PMID: 36229064 DOI: 10.26508/lsa.202201496] [Reference Citation Analysis]
|
| 43 |
Nkumama IN, Odera D, Musasia F, Mwai K, Nyamako L, Murungi L, Tuju J, Fürle K, Rosenkranz M, Kimathi R, Njuguna P, Hamaluba M, Kapulu MC, Frank R, Osier FHA, CHMI-SIKA study Team. Breadth of Fc-mediated effector function delineates grades of clinical immunity following human malaria challenge.. [DOI: 10.1101/2022.10.11.511755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 44 |
Pirmoradi S, Department of Biochemistry, Shahid Chamran University of Ahvaz, Ahvaz, Iran. In-silico Designing of Immunogenic Construct Based on Peptide Epitopes Using Immuno-informatics Tools Against Tuberculosis. Iran J Med Microbiol 2022;16:506-519. [DOI: 10.30699/ijmm.16.6.506] [Reference Citation Analysis]
|
| 45 |
Ford EE, Tieri D, Rodriguez O, Francoeur N, Soto J, Kos J, Gibson W, Silver CA, Deikus G, Hudson E, Woolley CR, Beckmann N, Charney A, Mitchell TC, Sebra RP, Watson CT, Smith ML. FLAIRR-seq: A novel method for single molecule resolution of near full-length immunoglobulin heavy chain repertoires.. [DOI: 10.1101/2022.09.24.509352] [Reference Citation Analysis]
|
| 46 |
Ankerhold J, Giese S, Kolb P, Maul-Pavicic A, Voll RE, Göppert N, Ciminski K, Kreutz C, Lother A, Salzer U, Bildl W, Welsink T, Morgenthaler NG, Grawitz AB, Emmerich F, Steinmann D, Huzly D, Schwemmle M, Hengel H, Falcone V. Circulating multimeric immune complexes contribute to immunopathology in COVID-19. Nat Commun 2022;13:5654. [PMID: 36163132 DOI: 10.1038/s41467-022-32867-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 47 |
Jia L, Weng S, Wu J, Tian X, Zhang Y, Wang X, Wang J, Yan D, Wang W, Fang F, Zhu Z, Qiu C, Zhang W, Xu Y, Wan Y. Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity. Gut Microbes 2022;14:2117503. [PMID: 36100957 DOI: 10.1080/19490976.2022.2117503] [Reference Citation Analysis]
|
| 48 |
Wei X, Rong N, Liu J. Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2. Front Immunol 2022;13:993754. [DOI: 10.3389/fimmu.2022.993754] [Reference Citation Analysis]
|
| 49 |
Cruz AR, Bentlage AEH, Blonk R, de Haas CJC, Aerts PC, Scheepmaker LM, Bouwmeester IG, Lux A, van Strijp JAG, Nimmerjahn F, van Kessel KPM, Vidarsson G, Rooijakkers SHM. Toward Understanding How Staphylococcal Protein A Inhibits IgG-Mediated Phagocytosis. The Journal of Immunology 2022;209:1146-1155. [DOI: 10.4049/jimmunol.2200080] [Reference Citation Analysis]
|
| 50 |
Karsten CB, Bartsch YC, Shin SA, Slein MD, Heller HM, Kolandaivelu K, Middeldorp JM, Alter G, Julg B. Evolution of functional antibodies following acute Epstein-Barr virus infection. PLoS Pathog 2022;18:e1010738. [DOI: 10.1371/journal.ppat.1010738] [Reference Citation Analysis]
|
| 51 |
Dolatshahi S, Butler AL, Pou C, Henckel E, Bernhardsson AK, Gustafsson A, Bohlin K, Shin SA, Lauffenburger DA, Brodin P, Alter G. Selective transfer of maternal antibodies in preterm and fullterm children. Sci Rep 2022;12:14937. [PMID: 36056073 DOI: 10.1038/s41598-022-18973-4] [Reference Citation Analysis]
|
| 52 |
Cerutti A, Filipska M, Fa XM, Tachó-Piñot R. Impact of the mucosal milieu on antibody responses to allergens. J Allergy Clin Immunol 2022;150:503-12. [PMID: 36075636 DOI: 10.1016/j.jaci.2022.07.007] [Reference Citation Analysis]
|
| 53 |
Le Gars M, Hendriks J, Sadoff J, Ryser M, Struyf F, Douoguih M, Schuitemaker H. Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector-based COVID-19 vaccine. Immunol Rev 2022;310:47-60. [PMID: 35689434 DOI: 10.1111/imr.13088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 54 |
Vacca F, Sala C, Rappuoli R. Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions. Biomedicines 2022;10:2126. [DOI: 10.3390/biomedicines10092126] [Reference Citation Analysis]
|
| 55 |
Baldwin SL, Reese VA, Larsen SE, Pecor T, Brown BP, Granger B, Podell BK, Fox CB, Reed SG, Coler RN. Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations. Front Microbiol 2022;13:935444. [PMID: 36090093 DOI: 10.3389/fmicb.2022.935444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 56 |
Shlesinger D, Hong KL, Shammas G, Page N, Sandu I, Agrafiotis A, Kreiner V, Fonta N, Vincenti I, Wagner I, Piccinno M, Mariotte A, Klimek B, Dizerens R, Manero-Carranza M, Kuhn R, Ehling R, Frei L, Khodaverdi K, Panetti C, Joller N, Oxenius A, Merkler D, Reddy ST, Yermanos A. Single-cell immune repertoire sequencing of B and T cells in murine models of infection and autoimmunity. Genes Immun 2022. [PMID: 36028771 DOI: 10.1038/s41435-022-00180-w] [Reference Citation Analysis]
|
| 57 |
Wang X, Liu P, Jiang Y, Han B, Yan L. The prophylactic effects of monoclonal antibodies targeting the cell wall Pmt4 protein epitopes of Candida albicans in a murine model of invasive candidiasis. Front Microbiol 2022;13:992275. [DOI: 10.3389/fmicb.2022.992275] [Reference Citation Analysis]
|
| 58 |
Bates TA, Lu P, Kang YJ, Schoen D, Thornton M, Mcbride SK, Park C, Kim D, Messer WB, Curlin ME, Tafesse FG, Lu LL. BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with age.. [DOI: 10.1101/2022.08.12.22278726] [Reference Citation Analysis]
|
| 59 |
Bernshtein B, Ndungo E, Cizmeci D, Xu P, Kováč P, Kelly M, Islam D, Ryan ET, Kotloff KL, Pasetti MF, Alter G. Systems approach to define humoral correlates of immunity to Shigella. Cell Rep 2022;40:111216. [PMID: 35977496 DOI: 10.1016/j.celrep.2022.111216] [Reference Citation Analysis]
|
| 60 |
Bruel T, Stéfic K, Nguyen Y, Toniutti D, Staropoli I, Porrot F, Guivel-benhassine F, Bolland W, Planas D, Hadjadj J, Handala L, Planchais C, Prot M, Simon-lorière E, André E, Baele G, Cuypers L, Mouthon L, Mouquet H, Buchrieser J, Sève A, Prazuck T, Maes P, Terrier B, Hocqueloux L, Schwartz O. Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4 and BA.5 in patients receiving monoclonal antibodies.. [DOI: 10.1101/2022.08.12.22278699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 61 |
Bigay J, Le Grand R, Martinon F, Maisonnasse P. Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development. Front Microbiol 2022;13:932408. [DOI: 10.3389/fmicb.2022.932408] [Reference Citation Analysis]
|
| 62 |
Davies LRL, Cizmeci D, Guo W, Luedemann C, Alexander-Parrish R, Grant L, Isturiz R, Theilacker C, Jodar L, Gessner BD, Alter G. Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses. Sci Transl Med 2022;14:eabm4065. [PMID: 35921476 DOI: 10.1126/scitranslmed.abm4065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 63 |
Leventhal SS, Meade-white K, Rao D, Haddock E, Leung J, Scott D, Archer J, Randall S, Erasmus JH, Feldmann H, Hawman DW. Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge. eBioMedicine 2022;82:104188. [DOI: 10.1016/j.ebiom.2022.104188] [Reference Citation Analysis]
|
| 64 |
de Vor L, Beudeker CR, Flier A, Scheepmaker LM, Aerts PC, Vijlbrief DC, Bekker MN, Beurskens FJ, van Kessel KPM, de Haas CJC, Rooijakkers SHM, van der Flier M. Monoclonal antibodies effectively potentiate complement activation and phagocytosis of Staphylococcus epidermidis in neonatal human plasma. Front Immunol 2022;13:933251. [DOI: 10.3389/fimmu.2022.933251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 65 |
Rammauro F, Carrión F, Olivero-Deibe N, Fló M, Ferreira A, Pritsch O, Bianchi S. Humoral immune response characterization of heterologous prime-boost vaccination with CoronaVac and BNT162b2. Vaccine 2022:S0264-410X(22)00911-2. [PMID: 35907676 DOI: 10.1016/j.vaccine.2022.07.023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 66 |
Callegari I, Schneider M, Berloffa G, Mühlethaler T, Holdermann S, Galli E, Roloff T, Boss R, Infanti L, Khanna N, Egli A, Buser A, Zimmer G, Derfuss T, Sanderson NSR. Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch. EMBO Rep 2022;23:e53956. [PMID: 35548920 DOI: 10.15252/embr.202153956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 67 |
Khan Z, Ualiyeva D, Amissah OB, Sapkota S, Hameed HMA, Zhang T. Insight Into Novel Anti-tuberculosis Vaccines by Using Immunoinformatics Approaches. Front Microbiol 2022;13:866873. [PMID: 35722321 DOI: 10.3389/fmicb.2022.866873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 68 |
Pantaleo G, Correia B, Fenwick C, Joo VS, Perez L. Antibodies to combat viral infections: development strategies and progress. Nat Rev Drug Discov 2022. [PMID: 35725925 DOI: 10.1038/s41573-022-00495-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 69 |
Ullah I, Beaudoin-bussières G, Symmes K, Cloutier M, Ducas E, Tauzin A, Laumaea A, Bégin P, Mothes W, Kumar P, Bazin R, Finzi A, Uchil PD. The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice.. [DOI: 10.1101/2022.06.10.495677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 70 |
Goldblatt D, Alter G, Crotty S, Plotkin SA. Correlates of protection against SARS-CoV-2 infection and COVID-19 disease. Immunol Rev 2022;310:6-26. [PMID: 35661178 DOI: 10.1111/imr.13091] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 27.0] [Reference Citation Analysis]
|
| 71 |
Shoda J, Tanaka S, Etori K, Hattori K, Kasuya T, Ikeda K, Maezawa Y, Suto A, Suzuki K, Nakamura J, Maezawa Y, Takemoto M, Betsholtz C, Yokote K, Ohtori S, Nakajima H. Semaphorin 3G exacerbates joint inflammation through the accumulation and proliferation of macrophages in the synovium. Arthritis Res Ther 2022;24:134. [PMID: 35659346 DOI: 10.1186/s13075-022-02817-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 72 |
Ghafouri T, Manavizadeh N. Design and simulation of a millifluidic device for differential detection of SARS-CoV-2 and H1N1 based on triboelectricity. Bioelectrochemistry 2022;145:108096. [DOI: 10.1016/j.bioelechem.2022.108096] [Reference Citation Analysis]
|
| 73 |
Griffin DE. Why does viral RNA sometimes persist after recovery from acute infections? PLoS Biol 2022;20:e3001687. [PMID: 35648781 DOI: 10.1371/journal.pbio.3001687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 74 |
Goel RR, Painter MM, Lundgreen KA, Apostolidis SA, Baxter AE, Giles JR, Mathew D, Pattekar A, Reynaldi A, Khoury DS, Gouma S, Hicks P, Dysinger S, Hicks A, Sharma H, Herring S, Korte S, Kc W, Oldridge DA, Erickson RI, Weirick ME, McAllister CM, Awofolaju M, Tanenbaum N, Dougherty J, Long S, D'Andrea K, Hamilton JT, McLaughlin M, Williams JC, Adamski S, Kuthuru O, Drapeau EM, Davenport MP, Hensley SE, Bates P, Greenplate AR, Wherry EJ. Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine. Cell 2022;185:1875-1887.e8. [PMID: 35523182 DOI: 10.1016/j.cell.2022.04.009] [Cited by in Crossref: 70] [Cited by in F6Publishing: 58] [Article Influence: 70.0] [Reference Citation Analysis]
|
| 75 |
Tarke A, Grifoni A, Sette A. Bioinformatic and Experimental Analysis of T Cell Immune Reactivity to SARS-CoV-2 and its Variants. Front Bioinform 2022;2:876380. [DOI: 10.3389/fbinf.2022.876380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 76 |
Ma L, Ouyang H, Su A, Zhang Y, Pang D, Zhang T, Sun R, Wang W, Xie Z, Lv D. AbSE Workflow: Rapid Identification of the Coding Sequence and Linear Epitope of the Monoclonal Antibody at the Single-cell Level. ACS Synth Biol 2022;11:1856-64. [PMID: 35503752 DOI: 10.1021/acssynbio.2c00018] [Reference Citation Analysis]
|
| 77 |
Diamanti E, Föhr J, Papageorgiou A, Herbst M, Jahn S. Immunologie in der dermatologischen Praxis – wieviel, warum, wann? Aktuelle Dermatologie 2022;48:201-8. [DOI: 10.1055/a-1699-5440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 78 |
Atyeo C, Shook LL, Nziza N, Deriso EA, Muir C, Baez AM, Lima RS, Demidkin S, Brigida S, De Guzman RM, Burns MD, Balazs AB, Fasano A, Yonker LM, Gray KJ, Alter G, Edlow AG. COVID-19 booster dose antibody response in pregnant, lactating, and nonpregnant women.. [DOI: 10.1101/2022.05.17.22275154] [Reference Citation Analysis]
|
| 79 |
Plichta J, Kuna P, Panek M. Monoclonal Antibodies as Potential COVID-19 Therapeutic Agents. COVID 2022;2:599-620. [DOI: 10.3390/covid2050045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 80 |
Vieira VA, Herbert N, Cromhout G, Adland E, Goulder P. Role of Early Life Cytotoxic T Lymphocyte and Natural Killer Cell Immunity in Paediatric HIV Cure/Remission in the Anti-Retroviral Therapy Era. Front Immunol 2022;13:886562. [PMID: 35634290 DOI: 10.3389/fimmu.2022.886562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 81 |
McGrath JJC, Li L, Wilson PC. Memory B cell diversity: insights for optimized vaccine design. Trends Immunol 2022;43:343-54. [PMID: 35393268 DOI: 10.1016/j.it.2022.03.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 82 |
Xiao L, Yang X, Li J, Zhang P, Tang S, Cao D, Chen S, Li H, Zhang W, Chen G, Ni G, Wang T, Liu X, Snoussi M. Caerin 1 Peptides, the Potential Jack-of-All-Trades for the Multiple Antibiotic-Resistant Bacterial Infection Treatment and Cancer Immunotherapy. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/7841219] [Reference Citation Analysis]
|
| 83 |
Carpenter SM, Lu LL. Leveraging Antibody, B Cell and Fc Receptor Interactions to Understand Heterogeneous Immune Responses in Tuberculosis. Front Immunol 2022;13:830482. [PMID: 35371092 DOI: 10.3389/fimmu.2022.830482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 84 |
Mouro V, Fischer A. Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines. Mucosal Immunol 2022;15:584-94. [PMID: 35505121 DOI: 10.1038/s41385-022-00517-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 85 |
Kaplonek P, Cizmeci D, Fischinger S, Collier AR, Suscovich T, Linde C, Broge T, Mann C, Amanat F, Dayal D, Rhee J, de St Aubin M, Nilles EJ, Musk ER, Menon AS, Saphire EO, Krammer F, Lauffenburger DA, Barouch DH, Alter G. mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions. Sci Transl Med 2022;:eabm2311. [PMID: 35348368 DOI: 10.1126/scitranslmed.abm2311] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 35.0] [Reference Citation Analysis]
|
| 86 |
Cavaco M, Castanho MARB, Neves V. The Use of Antibody-Antibiotic Conjugates to Fight Bacterial Infections. Front Microbiol 2022;13:835677. [PMID: 35330773 DOI: 10.3389/fmicb.2022.835677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 87 |
Tian Z, Yu C, Zhang W, Wu KL, Wang C, Gupta R, Xu Z, Wu L, Chen Y, Zhang XH, Xiao H. Bone-Specific Enhancement of Antibody Therapy for Breast Cancer Metastasis to Bone. ACS Cent Sci 2022;8:312-21. [PMID: 35355817 DOI: 10.1021/acscentsci.1c01024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 88 |
Bartsch YC, Tong X, Kang J, Avendaño MJ, Serrano EF, García-Salum T, Pardo-Roa C, Riquelme A, Cai Y, Renzi I, Stewart-Jones G, Chen B, Medina RA, Alter G. Omicron variant Spike-specific antibody binding and Fc activity is preserved in recipients of mRNA or inactivated COVID-19 vaccines. Sci Transl Med 2022;:eabn9243. [PMID: 35289637 DOI: 10.1126/scitranslmed.abn9243] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 89 |
Fons NR, Kines RC, Thompson CD, Day PM, Lowy DR, Schiller JT, Banks L. Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum Conditions. J Virol. [DOI: 10.1128/jvi.01857-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 90 |
Bharadwaj P, Shrestha S, Pongracz T, Concetta C, Sharma S, Le Moine A, de Haan N, Murakami N, Riella LV, Holovska V, Wuhrer M, Marchant A, Ackerman ME. Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation.. [DOI: 10.1101/2022.03.09.22272152] [Reference Citation Analysis]
|
| 91 |
Fuentes-Villalobos F, Garrido JL, Medina MA, Zambrano N, Ross N, Bravo F, Gaete-Argel A, Oyarzún-Arrau A, Amanat F, Soto-Rifo R, Valiente-Echeverría F, Ocampo R, Esveile C, Ferreira L, Cabrera J, Torres V, Rioseco ML, Riquelme R, Barría S, Alvarez R, Pinos Y, Krammer F, Calvo M, Barria MI; COVID-19 South Chile Group. Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence. Front Immunol 2022;13:796481. [PMID: 35197972 DOI: 10.3389/fimmu.2022.796481] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 92 |
Anthony SM, Hensley LE. Cocktail party: Low-dose antibody combinations deliver pan-ebolavirus protection. Cell 2022;185:943-945. [DOI: 10.1016/j.cell.2022.01.025] [Reference Citation Analysis]
|
| 93 |
Zhou J, Huang C, Zhu H, Chen Z. Focus on Dysregulated Adaptive Immunity in Chronic Hepatitis B: A Promising Direction for Immunotherapy. Infectious Microbes and Diseases 2022;4:7-12. [DOI: 10.1097/im9.0000000000000082] [Reference Citation Analysis]
|
| 94 |
Astorga-gamaza A, Grau-expósito J, Burgos J, Navarro J, Curran A, Planas B, Suanzes P, Falcó V, Genescà M, Buzon MJ. Identification of HIV-Reservoir Cells with Reduced Susceptibility to Antibody-Dependent Immune Response.. [DOI: 10.1101/2022.02.24.481766] [Reference Citation Analysis]
|
| 95 |
Kumra Ahnlide V, Kumra Ahnlide J, Wrighton S, Beech JP, Nordenfelt P. Nanoscale binding site localization by molecular distance estimation on native cell surfaces using topological image averaging. Elife 2022;11:e64709. [PMID: 35200140 DOI: 10.7554/eLife.64709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 96 |
Curtis AD 2nd, Saha PT, Dennis M, Berendam SJ, Ramasubramanian P, Cross KA, Alam SM, Ferrari G, Kozlowski PA, Fouda GG, Hudgens MG, Van Rompay KKA, Pollara J, Permar SR, De Paris K. Vaccine-Induced, High-Magnitude HIV Env-Specific Antibodies with Fc-Mediated Effector Functions Are Insufficient to Protect Infant Rhesus Macaques against Oral SHIV Infection. mSphere 2022;7:e0083921. [PMID: 35196125 DOI: 10.1128/msphere.00839-21] [Reference Citation Analysis]
|
| 97 |
Mittal A, Khattri A, Verma V. Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants. PLoS Pathog 2022;18:e1010260. [PMID: 35176090 DOI: 10.1371/journal.ppat.1010260] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 98 |
Shoda J, Tanaka S, Etori K, Hattori K, Kasuya T, Ikeda K, Maezawa Y, Suto A, Suzuki K, Nakamura J, Maezawa Y, Takemoto M, Betsholtz C, Yokote K, Ohtori S, Nakajima H. Semaphorin 3G exacerbates joint inflammation through the accumulation and proliferation of macrophages in the synovium.. [DOI: 10.1101/2022.02.12.480222] [Reference Citation Analysis]
|
| 99 |
Shlesinger D, Hong K, Shammas G, Page N, Sandu I, Agrafiotis A, Kreiner V, Fonta N, Vincenti I, Wagner I, Piccinno M, Mariotte A, Klimek B, Dizerens R, Manero-carranza M, Kuhn R, Ehling R, Frei L, Khodaverdi K, Panetti C, Joller N, Oxenius A, Merkler D, Reddy ST, Yermanos A. Single-cell immune repertoire sequencing of B and T cells in murine models of infection and autoimmunity.. [DOI: 10.1101/2022.02.07.479381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 100 |
Wahl I, Wardemann H. How to induce protective humoral immunity against Plasmodium falciparum circumsporozoite protein. J Exp Med 2022;219:e20201313. [PMID: 35006242 DOI: 10.1084/jem.20201313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 101 |
Dufloo J, Planchais C, Frémont S, Lorin V, Guivel-Benhassine F, Stefic K, Casartelli N, Echard A, Roingeard P, Mouquet H, Schwartz O, Bruel T. Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells. Nat Commun 2022;13:630. [PMID: 35110562 DOI: 10.1038/s41467-022-28307-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 102 |
Polmear J, Good-jacobson KL. Antibody glycosylation directs innate and adaptive immune collaboration. Current Opinion in Immunology 2022;74:125-32. [DOI: 10.1016/j.coi.2021.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 103 |
Pongracz T, Vidarsson G, Wuhrer M. Antibody glycosylation in COVID-19. Glycoconj J. [DOI: 10.1007/s10719-022-10044-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 104 |
Cruz AR, Bentlage AEH, Blonk R, de Haas CJC, Aerts PC, Scheepmaker LM, Bouwmeester IG, Lux A, van Strijp JAG, Nimmerjahn F, van Kessel KPM, Vidarsson G, Rooijakkers SHM. Staphylococcal protein A inhibits IgG-mediated phagocytosis by blocking the interaction of IgGs with FcγRs and FcRn.. [DOI: 10.1101/2022.01.21.477287] [Reference Citation Analysis]
|
| 105 |
Zumpano R, Manghisi M, Polli F, D’agostino C, Ietto F, Favero G, Mazzei F. Label-free magnetic nanoparticles-based electrochemical immunosensor for atrazine detection. Anal Bioanal Chem. [DOI: 10.1007/s00216-021-03838-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 106 |
Shin M, Kim K, Lee HJ, Lee R, Jung YJ, Park J, Hahn TW. Zika virus baculovirus-expressed envelope protein elicited humoral and cellular immunity in immunocompetent mice. Sci Rep 2022;12:660. [PMID: 35027643 DOI: 10.1038/s41598-021-04713-7] [Reference Citation Analysis]
|
| 107 |
Ford-Siltz LA, Tohma K, Parra GI. Understanding the relationship between norovirus diversity and immunity. Gut Microbes 2021;13:1-13. [PMID: 33783322 DOI: 10.1080/19490976.2021.1900994] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 108 |
Treger RS, Fink SL. Beyond Titer: Expanding the Scope of Clinical Autoantibody Testing. The Journal of Applied Laboratory Medicine 2022;7:99-113. [DOI: 10.1093/jalm/jfab123] [Reference Citation Analysis]
|
| 109 |
Pegu A, Xu L, DeMouth ME, Fabozzi G, March K, Almasri CG, Cully MD, Wang K, Yang ES, Dias J, Fennessey CM, Hataye J, Wei RR, Rao E, Casazza JP, Promsote W, Asokan M, McKee K, Schmidt SD, Chen X, Liu C, Shi W, Geng H, Foulds KE, Kao SF, Noe A, Li H, Shaw GM, Zhou T, Petrovas C, Todd JP, Keele BF, Lifson JD, Doria-Rose NA, Koup RA, Yang ZY, Nabel GJ, Mascola JR. Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeys. Cell Rep 2022;38:110199. [PMID: 34986348 DOI: 10.1016/j.celrep.2021.110199] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 110 |
Patel J. Pharmacological Management. Principles in Nursing Practice in the Era of COVID-19 2022. [DOI: 10.1007/978-3-030-94740-8_4] [Reference Citation Analysis]
|
| 111 |
Mirzaei HR. Adaptive Immunity. Encyclopedia of Infection and Immunity 2022. [DOI: 10.1016/b978-0-12-818731-9.00028-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 112 |
Kamle S, Li D, Lee CG, Elias JA. Methods for transient expression and purification of monoclonal antibodies in mammalian cells. Advances in Protein Molecular and Structural Biology Methods 2022. [DOI: 10.1016/b978-0-323-90264-9.00003-9] [Reference Citation Analysis]
|
| 113 |
Chen Z, Gao X, Yu D. Longevity of vaccine protection: Immunological mechanism, assessment methods, and improving strategy. VIEW 2022;3:20200103. [DOI: 10.1002/viw.20200103] [Reference Citation Analysis]
|
| 114 |
Das S, Kar SS, Samanta S, Banerjee J, Giri B, Dash SK. Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review. Immunol Res 2022;70:289-315. [PMID: 35192185 DOI: 10.1007/s12026-022-09265-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 115 |
Lai JY, Lim TS. Antibody Phage Display. Encyclopedia of Infection and Immunity 2022. [DOI: 10.1016/b978-0-12-818731-9.00168-3] [Reference Citation Analysis]
|
| 116 |
Hsu MN, Tay ZM, Lin WN, Wei S. Screening of Antigen-Specific Antibody-Secreting Cells. Handbook of Single-Cell Technologies 2022. [DOI: 10.1007/978-981-10-8953-4_27] [Reference Citation Analysis]
|
| 117 |
Hoque H, Sumaiya, Hasan M, Rahaman MM, Jewel GNA, Prodhan SH. Immunoinformatics guided design of a next generation epitope-based vaccine against Kaposi Sarcoma. Informatics in Medicine Unlocked 2022;31:100986. [DOI: 10.1016/j.imu.2022.100986] [Reference Citation Analysis]
|
| 118 |
Watson A, Maan H, Kolodkin-gal I, Freund NT. Antibodies Against Biofilms: Mechanisms and Applications. Springer Series on Biofilms 2022. [DOI: 10.1007/978-3-031-10992-8_11] [Reference Citation Analysis]
|
| 119 |
Jung K, Corrigan N, Wong EHH, Boyer C. Bioactive Synthetic Polymers. Adv Mater 2022;34:e2105063. [PMID: 34611948 DOI: 10.1002/adma.202105063] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 120 |
Houen G. Therapeutic Antibodies: An Overview. Methods Mol Biol 2022;2313:1-25. [PMID: 34478129 DOI: 10.1007/978-1-0716-1450-1_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 121 |
Di Pietro A, Polmear J, Cooper L, Damelang T, Hussain T, Hailes L, O'Donnell K, Udupa V, Mi T, Preston S, Shtewe A, Hershberg U, Turner SJ, La Gruta NL, Chung AW, Tarlinton DM, Scharer CD, Good-Jacobson KL. Targeting BMI-1 in B cells restores effective humoral immune responses and controls chronic viral infection. Nat Immunol 2022;23:86-98. [PMID: 34845392 DOI: 10.1038/s41590-021-01077-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 122 |
Pérez de la Lastra JM, Baca-González V, González-Acosta S, Asensio-Calavia P, Otazo-Pérez A, Morales-delaNuez A. Antibodies targeting enzyme inhibition as potential tools for research and drug development. Biomol Concepts 2021;12:215-32. [PMID: 35104929 DOI: 10.1515/bmc-2021-0021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 123 |
Bartsch Y, Tong X, Kang J, José Avendaño M, Serrano EF, García-Salum T, Pardo-Roa C, Riquelme A, Medina RA, Alter G. Preserved Omicron Spike specific antibody binding and Fc-recognition across COVID-19 vaccine platforms. medRxiv 2021:2021. [PMID: 34981072 DOI: 10.1101/2021.12.24.21268378] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 124 |
den Boer MA, Lai SH, Xue X, van Kampen MD, Bleijlevens B, Heck AJR. Comparative Analysis of Antibodies and Heavily Glycosylated Macromolecular Immune Complexes by Size-Exclusion Chromatography Multi-Angle Light Scattering, Native Charge Detection Mass Spectrometry, and Mass Photometry. Anal Chem 2021. [PMID: 34939405 DOI: 10.1021/acs.analchem.1c03656] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 125 |
Mcculloch L, Harris AJ, Malbon A, Daniels MJD, Younas M, Grainger JR, Allan SM, Smith CJ, Mccoll BW. Treatment with IgM-enriched intravenous immunoglobulins (IgM-IVIg) enhances clearance of stroke-associated bacterial lung infection.. [DOI: 10.1101/2021.12.16.472965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 126 |
Farkash I, Feferman T, Cohen-Saban N, Avraham Y, Morgenstern D, Mayuni G, Barth N, Lustig Y, Miller L, Shouval DS, Biber A, Kirgner I, Levin Y, Dahan R. Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern. Cell Rep 2021;37:110114. [PMID: 34883043 DOI: 10.1016/j.celrep.2021.110114] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 127 |
Quiros-Roldan E, Amadasi S, Zanella I, Degli Antoni M, Storti S, Tiecco G, Castelli F. Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives. Pharmaceuticals (Basel) 2021;14:1272. [PMID: 34959672 DOI: 10.3390/ph14121272] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 128 |
Bohländer F, Weißmüller S, Riehl D, Gutscher M, Schüttrumpf J, Faust S. The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin. Biomedicines 2021;9:1828. [PMID: 34944644 DOI: 10.3390/biomedicines9121828] [Reference Citation Analysis]
|
| 129 |
Chen H, Maul-Pavicic A, Holzer M, Huber M, Salzer U, Chevalier N, Voll RE, Hengel H, Kolb P. Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel. EMBO Mol Med 2021;:e14182. [PMID: 34842342 DOI: 10.15252/emmm.202114182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 130 |
Aterido A, López-lasanta M, Blanco F, Juan-mas A, García-vivar ML, Erra A, Pérez-garcía C, Sánchez-fernández SÁ, Sanmartí R, Fernández-nebro A, Alperi-lópez M, Tornero J, Ortiz AM, Fernández-cid CM, Palau N, Pan W, Byrne-steele M, Starenki D, Weber D, Rodriguez-nunez I, Han J, Myers RM, Marsal S, Julià A. Seven chain adaptive immune receptor repertoire analysis in rheumatoid arthritis: association to disease and clinically relevant phenotypes.. [DOI: 10.1101/2021.11.26.21266347] [Reference Citation Analysis]
|
| 131 |
Herman JD, Wang C, Loos C, Yoon H, Rivera J, Eugenia Dieterle M, Haslwanter D, Jangra RK, Bortz RH 3rd, Bar KJ, Julg B, Chandran K, Lauffenburger D, Pirofski LA, Alter G. Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response. Nat Commun 2021;12:6853. [PMID: 34824251 DOI: 10.1038/s41467-021-27201-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 132 |
Morales-Núñez JJ, Muñoz-Valle JF, Torres-Hernández PC, Hernández-Bello J. Overview of Neutralizing Antibodies and Their Potential in COVID-19. Vaccines (Basel) 2021;9:1376. [PMID: 34960121 DOI: 10.3390/vaccines9121376] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 133 |
Puentes F, Benkert P, Amor S, Kuhle J, Giovannoni G. Antibodies to neurofilament light as potential biomarkers in multiple sclerosis. BMJ Neurol Open 2021;3:e000192. [PMID: 34786556 DOI: 10.1136/bmjno-2021-000192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 134 |
Pullen KM, Atyeo C, Collier AY, Gray KJ, Belfort MB, Lauffenburger DA, Edlow AG, Alter G. Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection. Cell Rep 2021;37:109959. [PMID: 34739850 DOI: 10.1016/j.celrep.2021.109959] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 135 |
Noy-Porat T, Edri A, Alcalay R, Makdasi E, Gur D, Aftalion M, Evgy Y, Beth-Din A, Levy Y, Epstein E, Radinsky O, Zauberman A, Lazar S, Yitzhaki S, Marcus H, Porgador A, Rosenfeld R, Mazor O. Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies. Antibodies (Basel) 2021;10:45. [PMID: 34842604 DOI: 10.3390/antib10040045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 136 |
Li S, McCraw AJ, Gardner RA, Spencer DIR, Karagiannis SN, Wagner GK. Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors. Antibodies (Basel) 2021;10:44. [PMID: 34842612 DOI: 10.3390/antib10040044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 137 |
Rogers GL, Cannon PM. Genome edited B cells: a new frontier in immune cell therapies. Mol Ther 2021;29:3192-204. [PMID: 34563675 DOI: 10.1016/j.ymthe.2021.09.019] [Reference Citation Analysis]
|
| 138 |
Abernathy ME, Dam KA, Esswein SR, Jette CA, Bjorkman PJ. How Antibodies Recognize Pathogenic Viruses: Structural Correlates of Antibody Neutralization of HIV-1, SARS-CoV-2, and Zika. Viruses 2021;13:2106. [PMID: 34696536 DOI: 10.3390/v13102106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 139 |
Olsen TH, Boyles F, Deane CM. Observed Antibody Space: A diverse database of cleaned, annotated, and translated unpaired and paired antibody sequences. Protein Sci 2021. [PMID: 34655133 DOI: 10.1002/pro.4205] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 140 |
Curtis AD, Saha PT, Dennis M, Berendam SJ, Alam SM, Ferrari G, Kozlowski PA, Fouda G, Hudgens M, Van Rompay KK, Pollara J, Permar SR, De Paris K. Vaccine-induced, high magnitude HIV Env-specific antibodies with Fc-mediated effector functions are insufficient to protect infant rhesus macaques against oral SHIV infection.. [DOI: 10.1101/2021.10.11.464024] [Reference Citation Analysis]
|
| 141 |
Kubelkova K, Macela A. Francisella and Antibodies. Microorganisms 2021;9:2136. [PMID: 34683457 DOI: 10.3390/microorganisms9102136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 142 |
Hvilsom CT, Søgaard OS. TLR-Agonist Mediated Enhancement of Antibody-Dependent Effector Functions as Strategy For an HIV-1 Cure. Front Immunol 2021;12:704617. [PMID: 34630386 DOI: 10.3389/fimmu.2021.704617] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 143 |
Dauba A, Khamlichi AA. Long-Range Control of Class Switch Recombination by Transcriptional Regulatory Elements. Front Immunol 2021;12:738216. [PMID: 34594340 DOI: 10.3389/fimmu.2021.738216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 144 |
Wawrzyniak M, Morsy Y, Mladenov R, Tontodonati G, Turgay Y, Herwig S, Back J, Mally M, Faridmoayer A, Scharl M. Fucosylation and Sialylation of Fc-Fragment of anti-Tumour Necrosis Factor Alpha Antibodies do not Influence Their Immunogenicity in Monocyte-Derived Dendritic Cells. J Crohns Colitis 2021;15:1596-601. [PMID: 33631789 DOI: 10.1093/ecco-jcc/jjab038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 145 |
Ritzau-Jost J, Hutloff A. T Cell/B Cell Interactions in the Establishment of Protective Immunity. Vaccines (Basel) 2021;9:1074. [PMID: 34696182 DOI: 10.3390/vaccines9101074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 146 |
Yu Y, Wang M, Zhang X, Li S, Lu Q, Zeng H, Hou H, Li H, Zhang M, Jiang F, Wu J, Ding R, Zhou Z, Liu M, Si W, Zhu T, Li H, Ma J, Gu Y, She G, Li X, Zhang Y, Peng K, Huang W, Liu W, Wang Y. Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients. Signal Transduct Target Ther 2021;6:346. [PMID: 34561414 DOI: 10.1038/s41392-021-00759-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 147 |
Phelps M, Balazs AB. Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis. Front Immunol 2021;12:734304. [PMID: 34603314 DOI: 10.3389/fimmu.2021.734304] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 148 |
Ullah I, Prévost J, Ladinsky MS, Stone H, Lu M, Anand SP, Beaudoin-Bussières G, Symmes K, Benlarbi M, Ding S, Gasser R, Fink C, Chen Y, Tauzin A, Goyette G, Bourassa C, Medjahed H, Mack M, Chung K, Wilen CB, Dekaban GA, Dikeakos JD, Bruce EA, Kaufmann DE, Stamatatos L, McGuire AT, Richard J, Pazgier M, Bjorkman PJ, Mothes W, Finzi A, Kumar P, Uchil PD. Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy. Immunity 2021;54:2143-2158.e15. [PMID: 34453881 DOI: 10.1016/j.immuni.2021.08.015] [Cited by in Crossref: 68] [Cited by in F6Publishing: 78] [Article Influence: 34.0] [Reference Citation Analysis]
|
| 149 |
Mostaghimi D, Valdez CN, Larson HT, Kalinich CC, Iwasaki A. Prevention of host-to-host transmission by SARS-CoV-2 vaccines. Lancet Infect Dis 2021:S1473-3099(21)00472-2. [PMID: 34534512 DOI: 10.1016/S1473-3099(21)00472-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 150 |
Tan ZC, Murphy MC, Alpay HS, Taylor SD, Meyer AS. Tensor-structured decomposition improves systems serology analysis. Mol Syst Biol 2021;17:e10243. [PMID: 34487431 DOI: 10.15252/msb.202110243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 151 |
Tian Z, Yu C, Zhang W, Wu K, Gupta R, Xu Z, Wu L, Chen Y, Zhang XH-, Xiao H. Bone-Specific Enhancement of Antibody Therapy for Breast Cancer Metastasis to Bone.. [DOI: 10.1101/2021.08.31.457412] [Reference Citation Analysis]
|
| 152 |
Kim J, Lee JY, Kim HG, Kwak MW, Kang TH. Fc Receptor Variants and Disease: A Crucial Factor to Consider in the Antibody Therapeutics in Clinic. Int J Mol Sci 2021;22:9489. [PMID: 34502398 DOI: 10.3390/ijms22179489] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 153 |
Kaplonek P, Cizmeci D, Fischinger S, Collier AR, Suscovich T, Linde C, Broge T, Mann C, Amanat F, Dayal D, Rhee J, de St Aubin M, Nilles EJ, Musk ER, Menon AS, Saphire EO, Krammer F, Lauffenburger DA, Barouch DH, Alter G. Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles. bioRxiv 2021:2021. [PMID: 34494026 DOI: 10.1101/2021.08.31.458247] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 154 |
Porsch F, Mallat Z, Binder CJ. Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies. Cardiovasc Res 2021:cvab285. [PMID: 34450620 DOI: 10.1093/cvr/cvab285] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 155 |
Foreman HC, Frank A, Stedman TT. Determination of variable region sequences from hybridoma immunoglobulins that target Mycobacterium tuberculosis virulence factors. PLoS One 2021;16:e0256079. [PMID: 34415957 DOI: 10.1371/journal.pone.0256079] [Reference Citation Analysis]
|
| 156 |
Lee RH, Wang YJ, Lai TY, Hsu TL, Chuang PK, Wu HC, Wong CH. Combined Effect of Anti-SSEA4 and Anti-Globo H Antibodies on Breast Cancer Cells. ACS Chem Biol 2021;16:1526-37. [PMID: 34369155 DOI: 10.1021/acschembio.1c00396] [Reference Citation Analysis]
|
| 157 |
Mandó P, Rivero SG, Rizzo MM, Pinkasz M, Levy EM. Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era. Breast 2021;60:15-25. [PMID: 34454323 DOI: 10.1016/j.breast.2021.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 158 |
Masu Y, Kanazawa Y, Kakuta Y, Shimoyama Y, Onodera M, Naito T, Moroi R, Kuroha M, Kimura T, Shiga H, Kinouchi Y, Masamune A. Immunoglobulin subtype-coated bacteria are correlated with the disease activity of inflammatory bowel disease. Sci Rep 2021;11:16672. [PMID: 34404881 DOI: 10.1038/s41598-021-96289-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 159 |
Finney J, Kelsoe G. Continuous Culture of Mouse Primary B Lymphocytes by Forced Expression of Bach2. J Immunol 2021;207:1478-92. [PMID: 34389622 DOI: 10.4049/jimmunol.2100172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 160 |
di Tommaso A, Juste MO, Lakhrif Z, Mévélec MN, Borowczyk C, Hammeni P, Désoubeaux G, Van Langendonck N, Debierre-Grockiego F, Aubrey N, Dimier-Poisson I. Engineering and Functional Evaluation of Neutralizing Antibody Fragments Against Congenital Toxoplasmosis. J Infect Dis 2021;224:705-14. [PMID: 33728452 DOI: 10.1093/infdis/jiab141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 161 |
Fraley E, LeMaster C, Geanes E, Banerjee D, Khanal S, Grundberg E, Selvarangan R, Bradley T. Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals. BMC Med 2021;19:169. [PMID: 34304742 DOI: 10.1186/s12916-021-02055-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 162 |
Eaglesham JB, Garcia A, Berkmen M. Production of antibodies in SHuffle Escherichia coli strains. Methods Enzymol 2021;659:105-44. [PMID: 34752282 DOI: 10.1016/bs.mie.2021.06.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 163 |
Cruz AR, Boer MAD, Strasser J, Zwarthoff SA, Beurskens FJ, de Haas CJC, Aerts PC, Wang G, de Jong RN, Bagnoli F, van Strijp JAG, van Kessel KPM, Schuurman J, Preiner J, Heck AJR, Rooijakkers SHM. Staphylococcal protein A inhibits complement activation by interfering with IgG hexamer formation. Proc Natl Acad Sci U S A 2021;118:e2016772118. [PMID: 33563762 DOI: 10.1073/pnas.2016772118] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 164 |
Huseby Kelcher AM, Baehr CA, Hamid FA, Hart GT, Pravetoni M. Contribution of Antibody-Mediated Effector Functions to the Mechanism of Efficacy of Vaccines for Opioid Use Disorders. J Immunol 2021;207:860-7. [PMID: 34281999 DOI: 10.4049/jimmunol.2100204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 165 |
Jia L, Weng S, Wu J, Tian X, Zhang Y, Wang X, Wang J, Yan D, Wang W, Fang F, Zhu Z, Qiu C, Zhang W, Xu Y, Wan Y. Pre-existing antibodies targeting a linear epitope on SARS-CoV-2 S2 cross-reacted with commensal gut bacteria and shaped vaccine induced immunity.. [DOI: 10.1101/2021.07.13.21260404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 166 |
Farini A, Villa C, Tripodi L, Legato M, Torrente Y. Role of Immunoglobulins in Muscular Dystrophies and Inflammatory Myopathies. Front Immunol 2021;12:666879. [PMID: 34335568 DOI: 10.3389/fimmu.2021.666879] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 167 |
Whaley KJ, Zeitlin L. Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing. Hum Vaccin Immunother 2021;:1-11. [PMID: 34259613 DOI: 10.1080/21645515.2021.1930847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 168 |
Liu Z, Wu H, Egland KA, Gilliland TC, Dunn MD, Luke TC, Sullivan EJ, Klimstra WB, Bausch CL, Whelan SPJ. Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants. Hum Vaccin Immunother 2021;:1-10. [PMID: 34228597 DOI: 10.1080/21645515.2021.1940652] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 169 |
Tijani MK, Lugaajju A, Persson KEM. Naturally Acquired Antibodies against Plasmodium falciparum: Friend or Foe? Pathogens 2021;10:832. [PMID: 34357982 DOI: 10.3390/pathogens10070832] [Reference Citation Analysis]
|
| 170 |
Giron LB, Palmer CS, Liu Q, Yin X, Papasavvas E, Sharaf R, Etemad B, Damra M, Goldman AR, Tang HY, Johnston R, Mounzer K, Kostman JR, Tebas P, Landay A, Montaner LJ, Jacobson JM, Li JZ, Abdel-Mohsen M. Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. Nat Commun 2021;12:3922. [PMID: 34188039 DOI: 10.1038/s41467-021-24077-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 171 |
Ullah I, Prévost J, Ladinsky MS, Stone H, Lu M, Anand SP, Beaudoin-Bussières G, Symmes K, Benlarbi M, Ding S, Gasser R, Fink C, Chen Y, Tauzin A, Goyette G, Bourassa C, Medjahed H, Mack M, Chung K, Wilen CB, Dekaban GA, Dikeakos JD, Bruce EA, Kaufmann DE, Stamatatos L, McGuire AT, Richard J, Pazgier M, Bjorkman PJ, Mothes W, Finzi A, Kumar P, Uchil PD. Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal Efficacy. bioRxiv 2021:2021. [PMID: 33791699 DOI: 10.1101/2021.03.22.436337] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 172 |
Ankerhold J, Giese S, Kolb P, Maul-pavicic A, Voll RE, Göppert N, Ciminski K, Kreutz C, Lother A, Salzer U, Bildl W, Welsink T, Morgenthaler NG, Grawitz AB, Huzly D, Schwemmle M, Hengel H, Falcone V. Circulating multimeric immune complexes drive immunopathology in COVID-19.. [DOI: 10.1101/2021.06.25.449893] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 173 |
Suscovich TJ, Fallon JK, Das J, Demas AR, Crain J, Linde CH, Michell A, Natarajan H, Arevalo C, Broge T, Linnekin T, Kulkarni V, Lu R, Slein MD, Luedemann C, Marquette M, March S, Weiner J, Gregory S, Coccia M, Flores-Garcia Y, Zavala F, Ackerman ME, Bergmann-Leitner E, Hendriks J, Sadoff J, Dutta S, Bhatia SN, Lauffenburger DA, Jongert E, Wille-Reece U, Alter G. Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccination. Sci Transl Med 2020;12:eabb4757. [PMID: 32718991 DOI: 10.1126/scitranslmed.abb4757] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 31.0] [Reference Citation Analysis]
|
| 174 |
Singh SS, Heijmans R, Meulen CKE, Lieverse AG, Gornik O, Sijbrands EJG, Lauc G, van Hoek M. Association of the IgG N-glycome with the course of kidney function in type 2 diabetes. BMJ Open Diabetes Res Care 2020;8:e001026. [PMID: 32349995 DOI: 10.1136/bmjdrc-2019-001026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 175 |
Zwarthoff SA, Widmer K, Kuipers A, Strasser J, Ruyken M, Aerts PC, de Haas CJC, Ugurlar D, den Boer MA, Vidarsson G, van Strijp JAG, Gros P, Parren PWHI, van Kessel KPM, Preiner J, Beurskens FJ, Schuurman J, Ricklin D, Rooijakkers SHM. C1q binding to surface-bound IgG is stabilized by C1r2s2 proteases. Proc Natl Acad Sci U S A 2021;118:e2102787118. [PMID: 34155115 DOI: 10.1073/pnas.2102787118] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 176 |
Toh ZQ, Higgins RA, Mazarakis N, Abbott E, Nathanielsz J, Balloch A, Mulholland K, Licciardi PV. Evaluating Functional Immunity Following Encapsulated Bacterial Infection and Vaccination. Vaccines (Basel) 2021;9:677. [PMID: 34203030 DOI: 10.3390/vaccines9060677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 177 |
Uccellini MB, Aslam S, Liu STH, Alam F, García-Sastre A. Development of a Macrophage-Based ADCC Assay. Vaccines (Basel) 2021;9:660. [PMID: 34204268 DOI: 10.3390/vaccines9060660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 178 |
Lankipalli S, Ramagopal UA. A structural perspective on the design of decoy immune modulators. Pharmacol Res 2021;170:105735. [PMID: 34146695 DOI: 10.1016/j.phrs.2021.105735] [Reference Citation Analysis]
|
| 179 |
Shiakolas AR, Kramer KJ, Wrapp D, Richardson SI, Schäfer A, Wall S, Wang N, Janowska K, Pilewski KA, Venkat R, Parks R, Manamela NP, Raju N, Fechter EF, Holt CM, Suryadevara N, Chen RE, Martinez DR, Nargi RS, Sutton RE, Ledgerwood JE, Graham BS, Diamond MS, Haynes BF, Acharya P, Carnahan RH, Crowe JE Jr, Baric RS, Morris L, McLellan JS, Georgiev IS. Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions. Cell Rep Med 2021;2:100313. [PMID: 34056628 DOI: 10.1016/j.xcrm.2021.100313] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 20.5] [Reference Citation Analysis]
|
| 180 |
Yates JL, Ehrbar DJ, Hunt DT, Girardin RC, Dupuis AP 2nd, Payne AF, Sowizral M, Varney S, Kulas KE, Demarest VL, Howard KM, Carson K, Hales M, Ejemel M, Li Q, Wang Y, Peredo-Wende R, Ramani A, Singh G, Strle K, Mantis NJ, McDonough KA, Lee WT. Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity. Cell Rep Med 2021;2:100329. [PMID: 34151306 DOI: 10.1016/j.xcrm.2021.100329] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 181 |
Lambour J, Naranjo-Gomez M, Boyer-Clavel M, Pelegrin M. Differential and sequential immunomodulatory role of neutrophils and Ly6Chi inflammatory monocytes during antiviral antibody therapy. Emerg Microbes Infect 2021;10:964-81. [PMID: 33858301 DOI: 10.1080/22221751.2021.1913068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 182 |
Noy-porat T, Edri A, Alcalay R, Makdasi E, Gur D, Aftalion M, Evgy Y, Beth-din A, Levy Y, Epstein E, Radinsky O, Zauberman A, Lazar S, Yitzhaki S, Marcus H, Porgador A, Rosenfeld R, Mazor O. Fc-independent neutralization of SARS-CoV-2 by recombinant human monoclonal antibodies.. [DOI: 10.1101/2021.05.15.443978] [Reference Citation Analysis]
|
| 183 |
Geyer CE, Mes L, Newling M, den Dunnen J, Hoepel W. Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins. Cells 2021;10:1175. [PMID: 34065953 DOI: 10.3390/cells10051175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 184 |
Lemme-Dumit JM, Cazorla SI, Perdigón GDV, Maldonado-Galdeano C. Probiotic Bacteria and Their Cell Walls Induce Th1-Type Immunity Against Salmonella Typhimurium Challenge. Front Immunol 2021;12:660854. [PMID: 34054825 DOI: 10.3389/fimmu.2021.660854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 185 |
Irvine EB, O’neil A, Darrah PA, Shin S, Choudhary A, Li W, Honnen W, Mehra S, Kaushal D, Gideon HP, Flynn JL, Roederer M, Seder RA, Pinter A, Fortune S, Alter G. Robust IgM responses following vaccination are associated with prevention of Mycobacterium tuberculosis infection in macaques.. [DOI: 10.1101/2021.05.06.442979] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 186 |
Zhou X, Ma F, Xie J, Yuan M, Li Y, Shaabani N, Zhao F, Huang D, Wu NC, Lee CD, Liu H, Li J, Chen Z, Hong Y, Liu WH, Xiao N, Burton DR, Tu H, Li H, Chen X, Teijaro JR, Wilson IA, Xiao C, Huang Z. Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2. Cell Rep 2021;35:109109. [PMID: 33932326 DOI: 10.1016/j.celrep.2021.109109] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 187 |
Tolnay M. Lymphocytes sense antibodies through human FCRL proteins: Emerging roles in mucosal immunity. J Leukoc Biol 2021. [PMID: 33884658 DOI: 10.1002/JLB.4RU0221-102RR] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 188 |
Valdez-Cruz NA, García-Hernández E, Espitia C, Cobos-Marín L, Altamirano C, Bando-Campos CG, Cofas-Vargas LF, Coronado-Aceves EW, González-Hernández RA, Hernández-Peralta P, Juárez-López D, Ortega-Portilla PA, Restrepo-Pineda S, Zelada-Cordero P, Trujillo-Roldán MA. Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment. Microb Cell Fact 2021;20:88. [PMID: 33888152 DOI: 10.1186/s12934-021-01576-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 189 |
Adeniji OS, Giron LB, Purwar M, Zilberstein NF, Kulkarni AJ, Shaikh MW, Balk RA, Moy JN, Forsyth CB, Liu Q, Dweep H, Kossenkov A, Weiner DB, Keshavarzian A, Landay A, Abdel-Mohsen M. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions. mBio 2021;12:e00281-21. [PMID: 33879594 DOI: 10.1128/mBio.00281-21] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 190 |
Yaffe ZA, Naiman NE, Slyker J, Wines BD, Richardson BA, Hogarth PM, Bosire R, Farquhar C, Ngacha DM, Nduati R, John-Stewart G, Overbaugh J. Improved HIV-positive infant survival is correlated with high levels of HIV-specific ADCC activity in multiple cohorts. Cell Rep Med 2021;2:100254. [PMID: 33948582 DOI: 10.1016/j.xcrm.2021.100254] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 191 |
Dufloo J, Grzelak L, Staropoli I, Madec Y, Tondeur L, Anna F, Pelleau S, Wiedemann A, Planchais C, Buchrieser J, Robinot R, Ungeheuer MN, Mouquet H, Charneau P, White M, Lévy Y, Hoen B, Fontanet A, Schwartz O, Bruel T. Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies. Cell Rep Med 2021;2:100275. [PMID: 33899033 DOI: 10.1016/j.xcrm.2021.100275] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 192 |
Ols S, Yang L, Thompson EA, Pushparaj P, Tran K, Liang F, Lin A, Eriksson B, Karlsson Hedestam GB, Wyatt RT, Loré K. Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity. Cell Rep 2020;30:3964-3971.e7. [PMID: 32209459 DOI: 10.1016/j.celrep.2020.02.111] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 21.5] [Reference Citation Analysis]
|
| 193 |
Earnest JT, Holmes AC, Basore K, Mack M, Fremont DH, Diamond MS. The mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies. Cell Rep 2021;35:108962. [PMID: 33826892 DOI: 10.1016/j.celrep.2021.108962] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 194 |
Gebre MS, Brito LA, Tostanoski LH, Edwards DK, Carfi A, Barouch DH. Novel approaches for vaccine development. Cell 2021;184:1589-603. [PMID: 33740454 DOI: 10.1016/j.cell.2021.02.030] [Cited by in Crossref: 64] [Cited by in F6Publishing: 44] [Article Influence: 32.0] [Reference Citation Analysis]
|
| 195 |
Haddad-Boubaker S, Othman H, Touati R, Ayouni K, Lakhal M, Ben Mustapha I, Ghedira K, Kharrat M, Triki H. In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect. BMC Bioinformatics 2021;22:163. [PMID: 33771096 DOI: 10.1186/s12859-021-04045-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 196 |
Cui M, Huang J, Zhang S, Liu Q, Liao Q, Qiu X. Immunoglobulin Expression in Cancer Cells and Its Critical Roles in Tumorigenesis. Front Immunol 2021;12:613530. [PMID: 33841396 DOI: 10.3389/fimmu.2021.613530] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 197 |
Valldorf B, Hinz SC, Russo G, Pekar L, Mohr L, Klemm J, Doerner A, Krah S, Hust M, Zielonka S. Antibody display technologies: selecting the cream of the crop. Biol Chem 2021. [PMID: 33759431 DOI: 10.1515/hsz-2020-0377] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 198 |
Li D, Lou Y, Zhang Y, Liu S, Li J, Tao J. Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases. Theranostics 2021;11:5430-46. [PMID: 33859756 DOI: 10.7150/thno.53961] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 199 |
Herman JD, Wang C, Loos C, Yoon H, Rivera J, Dieterle ME, Haslwanter D, Jangra RK, Bortz RH, Bar KJ, Julg B, Chandran K, Lauffenburger D, Pirofski LA, Alter G. Functional Antibodies in COVID-19 Convalescent Plasma. medRxiv 2021:2021. [PMID: 33758875 DOI: 10.1101/2021.03.08.21253157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 200 |
Gentili M, Hacohen N. Some antibodies can dampen antiviral defences in people with severe COVID. Nature 2021;591:37-9. [PMID: 33654298 DOI: 10.1038/d41586-021-00352-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 201 |
Bahnan W, Happonen L, Khakzad H, Ahnlide VK, de Neergaard T, Wrighton S, André O, Bratanis E, Tang D, Hellmark T, Björck L, Shannon O, Malmström L, Malmström J, Nordenfelt P. A human monoclonal antibody bivalently binding two different epitopes in streptococcal M protein protects against infection.. [DOI: 10.1101/2021.03.01.433494] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 202 |
Singh S, Thompson JA, Yilmaz B, Li H, Weis S, Sobral D, Truglio M, Aires da Silva F, Aguiar S, Carlos AR, Rebelo S, Cardoso S, Gjini E, Nuñez G, Soares MP. Loss of α-gal during primate evolution enhanced antibody-effector function and resistance to bacterial sepsis. Cell Host & Microbe 2021;29:347-361.e12. [DOI: 10.1016/j.chom.2020.12.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 203 |
Case JB, Winkler ES, Errico JM, Diamond MS. On the road to ending the COVID-19 pandemic: Are we there yet? Virology 2021;557:70-85. [PMID: 33676349 DOI: 10.1016/j.virol.2021.02.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 204 |
Wang S, Liu D, Qu J, Zhu H, Chen C, Gibbons C, Greenway H, Wang P, Bollag RJ, Liu K, Li L. Streamlined Subclass-Specific Absolute Quantification of Serum IgG Glycopeptides Using Synthetic Isotope-Labeled Standards. Anal Chem 2021;93:4449-55. [PMID: 33630567 DOI: 10.1021/acs.analchem.0c04462] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 205 |
Rijnink WF, Ottenhoff THM, Joosten SA. B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis. Front Immunol 2021;12:640168. [PMID: 33679802 DOI: 10.3389/fimmu.2021.640168] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 206 |
Bartsch YC, Fischinger S, Siddiqui SM, Chen Z, Yu J, Gebre M, Atyeo C, Gorman MJ, Zhu AL, Kang J, Burke JS, Slein M, Gluck MJ, Beger S, Hu Y, Rhee J, Petersen E, Mormann B, Aubin MS, Hasdianda MA, Jambaulikar G, Boyer EW, Sabeti PC, Barouch DH, Julg BD, Musk ER, Menon AS, Lauffenburger DA, Nilles EJ, Alter G. Discrete SARS-CoV-2 antibody titers track with functional humoral stability. Nat Commun 2021;12:1018. [PMID: 33589636 DOI: 10.1038/s41467-021-21336-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 29.5] [Reference Citation Analysis]
|
| 207 |
Winkler ES, Gilchuk P, Yu J, Bailey AL, Chen RE, Chong Z, Zost SJ, Jang H, Huang Y, Allen JD, Case JB, Sutton RE, Carnahan RH, Darling TL, Boon ACM, Mack M, Head RD, Ross TM, Crowe JE Jr, Diamond MS. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell 2021;184:1804-1820.e16. [PMID: 33691139 DOI: 10.1016/j.cell.2021.02.026] [Cited by in Crossref: 187] [Cited by in F6Publishing: 202] [Article Influence: 93.5] [Reference Citation Analysis]
|
| 208 |
Webb NE, Bernshtein B, Alter G. Tissues: the unexplored frontier of antibody mediated immunity. Curr Opin Virol 2021;47:52-67. [PMID: 33581646 DOI: 10.1016/j.coviro.2021.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 209 |
Zwarthoff SA, Widmer K, Kuipers A, Strasser J, Ruyken M, Aerts PC, de Haas CJ, Ugurlar D, Vidarsson G, Van Strijp JAG, Gros P, Parren PW, van Kessel KP, Preiner J, Beurskens FJ, Schuurman J, Ricklin D, Rooijakkers SH. C1q binding to surface-bound IgG is stabilized by C1r2s2 proteases.. [DOI: 10.1101/2021.02.08.430229] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 210 |
Naranjo-Gomez M, Cahen M, Lambour J, Boyer-Clavel M, Pelegrin M. Immunomodulatory Role of NK Cells during Antiviral Antibody Therapy. Vaccines (Basel) 2021;9:137. [PMID: 33567792 DOI: 10.3390/vaccines9020137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 211 |
Wang EY, Mao T, Klein J, Dai Y, Huck JD, Liu F, Zheng NS, Zhou T, Israelow B, Wong P, Lucas C, Silva J, Oh JE, Song E, Perotti ES, Fischer S, Campbell M, Fournier JB, Wyllie AL, Vogels CBF, Ott IM, Kalinich CC, Petrone ME, Watkins AE, Cruz CD, Farhadian SF, Schulz WL, Grubaugh ND, Ko AI, Iwasaki A, Ring AM; Yale IMPACT Team. Diverse Functional Autoantibodies in Patients with COVID-19. medRxiv 2021:2020. [PMID: 33330894 DOI: 10.1101/2020.12.10.20247205] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 36.0] [Reference Citation Analysis]
|
| 212 |
Carrillo J, Izquierdo-Useros N, Ávila-Nieto C, Pradenas E, Clotet B, Blanco J. Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity. Biochem Biophys Res Commun 2021;538:187-91. [PMID: 33187644 DOI: 10.1016/j.bbrc.2020.10.108] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 27.5] [Reference Citation Analysis]
|
| 213 |
Lacroix-Desmazes S, Pratt KP. Editorial: Tolerating Factor VIII: Novel Strategies to Prevent and Reverse Neutralizing Anti-FVIII Antibodies. Front Immunol 2020;11:639386. [PMID: 33569066 DOI: 10.3389/fimmu.2020.639386] [Reference Citation Analysis]
|
| 214 |
van der Graaf A, Zorro MM, Claringbould A, Võsa U, Aguirre-Gamboa R, Li C, Mooiweer J, Ricaño-Ponce I, Borek Z, Koning F, Kooy-Winkelaar Y, Sollid LM, Qiao SW, Kumar V, Li Y, Franke L, Withoff S, Wijmenga C, Sanna S, Jonkers I; BIOS Consortium. Systematic Prioritization of Candidate Genes in Disease Loci Identifies TRAFD1 as a Master Regulator of IFNγ Signaling in Celiac Disease. Front Genet 2020;11:562434. [PMID: 33569077 DOI: 10.3389/fgene.2020.562434] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 215 |
Suprun M, Ellis RJ, Sampson HA, Suárez-Fariñas M. bbeaR: an R package and framework for epitope-specific antibody profiling. Bioinformatics 2021:btaa1064. [PMID: 33471075 DOI: 10.1093/bioinformatics/btaa1064] [Reference Citation Analysis]
|
| 216 |
Sen-Kilic E, Blackwood CB, Huckaby AB, Horspool AM, Weaver KL, Malkowski AC, Witt WT, Bevere JR, Damron FH, Barbier M. Defining the Mechanistic Correlates of Protection Conferred by Whole-Cell Vaccination against Pseudomonas aeruginosa Acute Murine Pneumonia. Infect Immun 2021;89:e00451-20. [PMID: 33199354 DOI: 10.1128/IAI.00451-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 217 |
Desikan R, Antia R, Dixit NM. Physical 'strength' of the multi-protein chain connecting immune cells: Does the weakest link limit antibody affinity maturation?: The weakest link in the multi-protein chain facilitating antigen acquisition by B cells in germinal centres limits antibody affinity maturation. Bioessays 2021;43:e2000159. [PMID: 33448042 DOI: 10.1002/bies.202000159] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 218 |
Bibi S, Ullah I, Zhu B, Adnan M, Liaqat R, Kong WB, Niu S. In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology. Sci Rep 2021;11:1249. [PMID: 33441913 DOI: 10.1038/s41598-020-80899-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 27.0] [Reference Citation Analysis]
|
| 219 |
Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 2021;184:861-80. [PMID: 33497610 DOI: 10.1016/j.cell.2021.01.007] [Cited by in Crossref: 769] [Cited by in F6Publishing: 512] [Article Influence: 384.5] [Reference Citation Analysis]
|
| 220 |
Adeniji OS, Giron LB, Zilberstein NF, Shaikh MW, Balk RA, Moy JN, Forsyth CB, Keshavarzian A, Landay A, Abdel-mohsen M. COVID-19 Severity Is Associated with Differential Antibody Fc-mediated Innate Immune Functions.. [DOI: 10.1101/2021.01.11.426209] [Reference Citation Analysis]
|
| 221 |
van Gool MMJ, van Egmond M. IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity. Immunotargets Ther 2020;9:351-72. [PMID: 33447585 DOI: 10.2147/ITT.S266242] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 222 |
Murphy M, Taylor SD, Meyer AS. Structured decomposition improves systems serology prediction and interpretation.. [DOI: 10.1101/2021.01.03.425138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 223 |
Li C, Xu Z. The development of human monoclonal antibodies against Zika virus. Zika Virus Impact, Diagnosis, Control, and Models 2021. [DOI: 10.1016/b978-0-12-820267-8.00034-0] [Reference Citation Analysis]
|
| 224 |
Wira CR, Rodríguez-garcía M, Shen Z, Patel MV. Endocrine control of mucosal immunity in the human female reproductive tract: Bridging implantation with pathogen protection. Reproductive Immunology 2021. [DOI: 10.1016/b978-0-12-818508-7.00013-0] [Reference Citation Analysis]
|
| 225 |
Kang SH, Lee CH. Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy. Biotechnol Bioprocess Eng 2021;26:295-311. [PMID: 34220207 DOI: 10.1007/s12257-020-0181-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 226 |
Chen T, Blanc C, Liu Y, Ishida E, Singer S, Xu J, Joe M, Jenny-Avital ER, Chan J, Lowary TL, Achkar JM. Capsular glycan recognition provides antibody-mediated immunity against tuberculosis. J Clin Invest 2020;130:1808-22. [PMID: 31935198 DOI: 10.1172/JCI128459] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 227 |
Winkler ES, Gilchuk P, Yu J, Bailey AL, Chen RE, Zost SJ, Jang H, Huang Y, Allen JD, Case JB, Sutton RE, Carnahan RH, Darling TL, Boon ACM, Mack M, Head RD, Ross TM, Crowe JE, Diamond MS. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection. bioRxiv 2020:2020. [PMID: 33398272 DOI: 10.1101/2020.12.28.424554] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 228 |
Shiakolas AR, Kramer KJ, Wrapp D, Richardson SI, Schäfer A, Wall S, Wang N, Janowska K, Pilewski KA, Venkat R, Parks R, Manamela NP, Raju N, Fechter EF, Holt CM, Suryadevara N, Chen RE, Martinez DR, Nargi RS, Sutton RE, Ledgerwood JE, Graham BS, Diamond MS, Haynes BF, Acharya P, Carnahan RH, Crowe JE, Baric RS, Morris L, McLellan JS, Georgiev IS. Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions. bioRxiv 2020:2020. [PMID: 33398266 DOI: 10.1101/2020.12.20.414748] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 229 |
Galipeau Y, Greig M, Liu G, Driedger M, Langlois MA. Humoral Responses and Serological Assays in SARS-CoV-2 Infections. Front Immunol 2020;11:610688. [PMID: 33391281 DOI: 10.3389/fimmu.2020.610688] [Cited by in Crossref: 130] [Cited by in F6Publishing: 133] [Article Influence: 43.3] [Reference Citation Analysis]
|
| 230 |
Cai Y, Yin W. The Multiple Functions of B Cells in Chronic HBV Infection. Front Immunol 2020;11:582292. [PMID: 33381113 DOI: 10.3389/fimmu.2020.582292] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 231 |
Zohar T, Loos C, Fischinger S, Atyeo C, Wang C, Slein MD, Burke J, Yu J, Feldman J, Hauser BM, Caradonna T, Schmidt AG, Cai Y, Streeck H, Ryan ET, Barouch DH, Charles RC, Lauffenburger DA, Alter G. Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality. Cell 2020;183:1508-1519.e12. [PMID: 33207184 DOI: 10.1016/j.cell.2020.10.052] [Cited by in Crossref: 202] [Cited by in F6Publishing: 208] [Article Influence: 67.3] [Reference Citation Analysis]
|
| 232 |
Diamos AG, Pardhe MD, Sun H, Hunter JGL, Kilbourne J, Chen Q, Mason HS. A Highly Expressing, Soluble, and Stable Plant-Made IgG Fusion Vaccine Strategy Enhances Antigen Immunogenicity in Mice Without Adjuvant. Front Immunol 2020;11:576012. [PMID: 33343565 DOI: 10.3389/fimmu.2020.576012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 233 |
Tandale JB, Badgujar SB, Tandale BU, Angre U, Daftary SB, Lala S, Gaur VP. An improved protocol for large scale production of high purity 'Fc' fragment of human immunoglobulin G (IgG-Fc). J Chromatogr B Analyt Technol Biomed Life Sci 2020;1159:122400. [PMID: 33126073 DOI: 10.1016/j.jchromb.2020.122400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 234 |
Saha A, Dixit NM. Pre-existing resistance in the latent reservoir can compromise VRC01 therapy during chronic HIV-1 infection. PLoS Comput Biol 2020;16:e1008434. [PMID: 33253162 DOI: 10.1371/journal.pcbi.1008434] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 235 |
Pecetta S, Finco O, Seubert A. Quantum leap of monoclonal antibody (mAb) discovery and development in the COVID-19 era. Semin Immunol 2020;50:101427. [PMID: 33277154 DOI: 10.1016/j.smim.2020.101427] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 236 |
Lai JY, Lim TS. Infectious disease antibodies for biomedical applications: A mini review of immune antibody phage library repertoire. Int J Biol Macromol 2020;163:640-8. [PMID: 32650013 DOI: 10.1016/j.ijbiomac.2020.06.268] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 237 |
Hoepel W, Allahverdiyeva S, Harbiye H, de Taeye SW, van der Ham AJ, de Boer L, Zaat SAJ, van Weeghel M, Baeten DLP, Houtkooper RH, Everts B, Vidarsson G, den Dunnen J. IgG Subclasses Shape Cytokine Responses by Human Myeloid Immune Cells through Differential Metabolic Reprogramming. J Immunol 2020;205:3400-7. [PMID: 33188071 DOI: 10.4049/jimmunol.2000263] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 238 |
Chen H, Maul-pavicic A, Holzer M, Huber M, Salzer U, Chevalier N, Voll RE, Hengel H, Kolb P. Detection and functional resolution of soluble multimeric immune complexes by a comprehensive FcγR reporter cell panel.. [DOI: 10.1101/2020.11.11.378232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 239 |
Giron LB, Palmer CS, Liu Q, Yin X, Papasavvas E, Damra M, Goldman AR, Tang H, Johnston R, Mounzer K, Kostman JR, Tebas P, Landay A, Montaner LJ, Jacobson JM, Li JZ, Abdel-mohsen M. Non-Invasive Plasma Glycomic and Metabolic Biomarkers of Post-treatment Control of HIV.. [DOI: 10.1101/2020.11.11.378174] [Reference Citation Analysis]
|
| 240 |
Ali MG, Zhang Z, Gao Q, Pan M, Rowan EG, Zhang J. Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview. Immunol Res 2020;68:325-39. [PMID: 33161557 DOI: 10.1007/s12026-020-09159-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 241 |
Ahnlide VK, Ahnlide JK, Beech JP, Nordenfelt P. Binding site localization on non-homogeneous cell surfaces using topological image averaging.. [DOI: 10.1101/2020.11.03.366476] [Reference Citation Analysis]
|
| 242 |
Aydillo T, Escalera A, Strohmeier S, Aslam S, Sanchez-Cespedes J, Ayllon J, Roca-Oporto C, Perez-Romero P, Montejo M, Gavalda J, Munoz P, Lopez-Medrano F, Carratala J, Krammer F, García-Sastre A, Cordero E. Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients. Cell Rep Med 2020;1:100130. [PMID: 33294855 DOI: 10.1016/j.xcrm.2020.100130] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 243 |
Chen SM, Zou Z, Guo SY, Hou WT, Qiu XR, Zhang Y, Song LJ, Hu XY, Jiang YY, Shen H, An MM. Preventing Candida albicans from subverting host plasminogen for invasive infection treatment. Emerg Microbes Infect 2020;9:2417-32. [PMID: 33115324 DOI: 10.1080/22221751.2020.1840927] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 244 |
Jones K, Savulescu AF, Brombacher F, Hadebe S. Immunoglobulin M in Health and Diseases: How Far Have We Come and What Next? Front Immunol 2020;11:595535. [PMID: 33193450 DOI: 10.3389/fimmu.2020.595535] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 245 |
Ng'uni T, Chasara C, Ndhlovu ZM. Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions. Front Immunol 2020;11:590780. [PMID: 33193428 DOI: 10.3389/fimmu.2020.590780] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 246 |
Huang M, Liu X, Ye H, Zhao X, Zhao J, Liu Y, He X, Qu M, Pan J, Hou B, Cheng Y, Liu Z, Li Z, Liu L, Sun J, Zhang S, Zhang Z. Metabolic defects in splenic B cell compartments from patients with liver cirrhosis. Cell Death Dis 2020;11:915. [PMID: 33099582 DOI: 10.1038/s41419-020-03060-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 247 |
Farrington LA, Callaway PC, Vance HM, Baskevitch K, Lutz E, Warrier L, McIntyre TI, Budker R, Jagannathan P, Nankya F, Musinguzi K, Nalubega M, Sikyomu E, Naluwu K, Arinaitwe E, Dorsey G, Kamya MR, Feeney ME. Opsonized antigen activates Vδ2+ T cells via CD16/FCγRIIIa in individuals with chronic malaria exposure. PLoS Pathog 2020;16:e1008997. [PMID: 33085728 DOI: 10.1371/journal.ppat.1008997] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 248 |
Hyun JY, Lee CH, Lee H, Jang WD, Shin I. Bacterial Lectin-Targeting Glycoconjugates for Selective Elimination of Pathogenic Bacteria. ACS Macro Lett 2020;9:1429-32. [PMID: 35653658 DOI: 10.1021/acsmacrolett.0c00454] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 249 |
Andualem H, Kiros M, Getu S, Hailemichael W. Immunoglobulin G2 Antibody as a Potential Target for COVID-19 Vaccine. Immunotargets Ther 2020;9:143-9. [PMID: 33062618 DOI: 10.2147/ITT.S274746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 250 |
Klessing S, Temchura V, Tannig P, Peter AS, Christensen D, Lang R, Überla K. CD4+ T Cells Induced by Tuberculosis Subunit Vaccine H1 Can Improve the HIV-1 Env Humoral Response by Intrastructural Help. Vaccines (Basel) 2020;8:E604. [PMID: 33066267 DOI: 10.3390/vaccines8040604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 251 |
Suprun M, Getts R, Grishina G, Tsuang A, Suárez-Fariñas M, Sampson HA. Ovomucoid epitope-specific repertoire of IgE, IgG4 , IgG1 , IgA1 , and IgD antibodies in egg-allergic children. Allergy 2020;75:2633-43. [PMID: 32391917 DOI: 10.1111/all.14357] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 252 |
Khurana S, Ravichandran S, Hahn M, Coyle EM, Stonier SW, Zak SE, Kindrachuk J, Davey RT Jr, Dye JM, Chertow DS. Longitudinal Human Antibody Repertoire against Complete Viral Proteome from Ebola Virus Survivor Reveals Protective Sites for Vaccine Design. Cell Host Microbe 2020;27:262-276.e4. [PMID: 32053790 DOI: 10.1016/j.chom.2020.01.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 253 |
Heiss K, Heidepriem J, Fischer N, Weber LK, Dahlke C, Jaenisch T, Loeffler FF. Rapid Response to Pandemic Threats: Immunogenic Epitope Detection of Pandemic Pathogens for Diagnostics and Vaccine Development Using Peptide Microarrays. J Proteome Res 2020;19:4339-54. [PMID: 32892628 DOI: 10.1021/acs.jproteome.0c00484] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 254 |
Boudreau CM, Yu WH, Suscovich TJ, Talbot HK, Edwards KM, Alter G. Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination. J Clin Invest 2020;130:662-72. [PMID: 31845904 DOI: 10.1172/JCI129520] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 255 |
Moser BA, Steinhardt RC, Escalante-buendia Y, Boltz DA, Barker KM, Cassaidy BJ, Rosenberger M, Yoo S, Mcgonnigal BG, Esser-kahn AP. Increased vaccine tolerability and protection via NF-κB modulation. Sci Adv 2020;6:eaaz8700. [DOI: 10.1126/sciadv.aaz8700] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 256 |
Motley MP, Diago-Navarro E, Banerjee K, Inzerillo S, Fries BC. The Role of IgG Subclass in Antibody-Mediated Protection against Carbapenem-Resistant Klebsiella pneumoniae. mBio 2020;11:e02059-20. [PMID: 32900809 DOI: 10.1128/mBio.02059-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 257 |
Sunita, Singhvi N, Singh Y, Shukla P. Computational approaches in epitope design using DNA binding proteins as vaccine candidate in Mycobacterium tuberculosis. Infect Genet Evol 2020;83:104357. [PMID: 32438080 DOI: 10.1016/j.meegid.2020.104357] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 258 |
Verkerke HP, Maier CL. Towards characterized convalescent plasma for COVID-19: The dose matters. EClinicalMedicine 2020;26:100545. [PMID: 32984783 DOI: 10.1016/j.eclinm.2020.100545] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 259 |
Chen X, Shi M, Tong X, Kim HK, Wang LX, Schneewind O, Missiakas D. Glycosylation-dependent opsonophagocytic activity of staphylococcal protein A antibodies. Proc Natl Acad Sci U S A 2020;117:22992-3000. [PMID: 32855300 DOI: 10.1073/pnas.2003621117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 260 |
Desikan R, Raja R, Dixit NM. Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection. PLoS Comput Biol 2020;16:e1008064. [PMID: 32817614 DOI: 10.1371/journal.pcbi.1008064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 261 |
Koch T, Rottstegge M, Ruibal P, Gomez-Medina S, Nelson EV, Escudero-Pérez B, Pillny M, Ly ML, Koundouno FR, Bore JA, Magassouba N, Dahlke C, Günther S, Carroll MW, Addo MM, Muñoz-Fontela C. Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins. Viruses 2020;12:E915. [PMID: 32825479 DOI: 10.3390/v12090915] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 262 |
Giron LB, Colomb F, Papasavvas E, Azzoni L, Yin X, Fair M, Anzurez A, Damra M, Mounzer K, Kostman JR, Tebas P, O'Doherty U, Tateno H, Liu Q, Betts MR, Montaner LJ, Abdel-Mohsen M. Interferon-α alters host glycosylation machinery during treated HIV infection. EBioMedicine 2020;59:102945. [PMID: 32827942 DOI: 10.1016/j.ebiom.2020.102945] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 263 |
Sintou A, Mansfield C, Iacob A, Chowdhury RA, Narodden S, Rothery SM, Podovei R, Sanchez-Alonso JL, Ferraro E, Swiatlowska P, Harding SE, Prasad S, Rosenthal N, Gorelik J, Sattler S. Mediastinal Lymphadenopathy, Class-Switched Auto-Antibodies and Myocardial Immune-Complexes During Heart Failure in Rodents and Humans. Front Cell Dev Biol 2020;8:695. [PMID: 32850816 DOI: 10.3389/fcell.2020.00695] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 264 |
Gilchuk P, Bombardi RG, Erasmus JH, Tan Q, Nargi R, Soto C, Abbink P, Suscovich TJ, Durnell LA, Khandhar A, Archer J, Liang J, Fouch ME, Davidson E, Doranz BJ, Jones T, Larson E, Ertel S, Granger B, Fuerte-Stone J, Roy V, Broge T, Linnekin TC, Linde CH, Gorman MJ, Nkolola J, Alter G, Reed SG, Barouch DH, Diamond MS, Crowe JE Jr, Van Hoeven N, Thackray LB, Carnahan RH. Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics. Nat Biomed Eng 2020;4:1030-43. [PMID: 32747832 DOI: 10.1038/s41551-020-0594-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 265 |
Loos C, Lauffenburger DA, Alter G. Dissecting the antibody-OME: past, present, and future. Curr Opin Immunol 2020;65:89-96. [PMID: 32755751 DOI: 10.1016/j.coi.2020.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 266 |
Agarwal D, Allman D, Naji A. Novel therapeutic opportunities afforded by plasma cell biology in transplantation. Am J Transplant 2020;20:1984-91. [PMID: 32034987 DOI: 10.1111/ajt.15813] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 267 |
Murin CD. Considerations of Antibody Geometric Constraints on NK Cell Antibody Dependent Cellular Cytotoxicity. Front Immunol 2020;11:1635. [PMID: 32849559 DOI: 10.3389/fimmu.2020.01635] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 268 |
Ermakov EA, Nevinsky GA, Buneva VN. Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States. Int J Mol Sci 2020;21:E5392. [PMID: 32751323 DOI: 10.3390/ijms21155392] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 269 |
Motley MP, Diago-navarro E, Banerjee K, Inzerillo S, Fries BC. The Role of IgG Subclass in Antibody-Mediated Protection against Carbapenem-Resistant Klebsiella pneumoniae.. [DOI: 10.1101/2020.07.24.220780] [Reference Citation Analysis]
|
| 270 |
Cruz AR, den Boer MA, Strasser J, Beurskens FJ, de Haas CJC, Aerts PC, Wang G, de Jong RN, Bagnoli F, van Strijp JAG, van Kessel KPM, Schuurman J, Preiner J, Heck AJR, Rooijakkers SHM. Staphylococcal protein A inhibits complement activation by interfering with IgG hexamer formation.. [DOI: 10.1101/2020.07.20.212118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 271 |
Wang P, Gajjar MR, Yu J, Padte NN, Gettie A, Blanchard JL, Russell-Lodrigue K, Liao LE, Perelson AS, Huang Y, Ho DD. Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivo. Proc Natl Acad Sci U S A 2020;117:18002-9. [PMID: 32665438 DOI: 10.1073/pnas.2008190117] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 272 |
Diamos AG, Pardhe MD, Sun H, Hunter JGL, Kilbourne J, Chen Q, Mason HS. A highly expressing, soluble, and stable plant-made IgG fusion vaccine strategy enhances antigen immunogenicity in mice without adjuvant.. [DOI: 10.1101/2020.07.13.199703] [Reference Citation Analysis]
|
| 273 |
Arvin AM, Fink K, Schmid MA, Cathcart A, Spreafico R, Havenar-daughton C, Lanzavecchia A, Corti D, Virgin HW. A perspective on potential antibody-dependent enhancement of SARS-CoV-2. Nature 2020;584:353-63. [DOI: 10.1038/s41586-020-2538-8] [Cited by in Crossref: 334] [Cited by in F6Publishing: 339] [Article Influence: 111.3] [Reference Citation Analysis]
|
| 274 |
Singh S, Thompson JA, Weis S, Sobral D, Truglio M, Yilmaz B, Rebelo S, Cardoso S, Gjini E, Nuñez G, Soares MP. A trade-off between resistance to infection and reproduction in primate evolution.. [DOI: 10.1101/2020.07.10.186742] [Reference Citation Analysis]
|
| 275 |
Caruffo M, Mandakovic D, Cabrera P, Pacheco I, Montt L, Chávez‐báez I, Mejías M, Vera‐tamargo F, Perez‐valenzuela J, Carrasco‐labra A, Pulgar R. Insights into gene expression responses to infections in teleosts using microarray data: a systematic review. Rev Aquacult 2021;13:18-42. [DOI: 10.1111/raq.12462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 276 |
Weilhammer DR, Dunkle AD, Boone T, Gilmore SF, Khemmani M, Peters SKG, Hoeprich PD, Fischer NO, Blanchette CD, Driks A, Rasley A. Characterization of Bacillus anthracis Spore Proteins Using a Nanoscaffold Vaccine Platform. Front Immunol 2020;11:1264. [PMID: 32714323 DOI: 10.3389/fimmu.2020.01264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 277 |
Naranjo-Gomez M, Pelegrin M. Vaccinal effect of HIV-1 antibody therapy. Curr Opin HIV AIDS 2019;14:325-33. [PMID: 30973419 DOI: 10.1097/COH.0000000000000555] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 278 |
Carabali-Isajar ML, Ocampo M, Varela Y, Díaz-Arévalo D, Patarroyo MA, Patarroyo ME. Antibodies targeting Mycobacterium tuberculosis peptides inhibit mycobacterial entry to infection target cells. Int J Biol Macromol 2020;161:712-20. [PMID: 32522539 DOI: 10.1016/j.ijbiomac.2020.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 279 |
Sandonís V, García-Ríos E, McConnell MJ, Pérez-Romero P. Role of Neutralizing Antibodies in CMV Infection: Implications for New Therapeutic Approaches. Trends Microbiol 2020;28:900-12. [PMID: 32448762 DOI: 10.1016/j.tim.2020.04.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 280 |
Gilchuk P, Bombardi RG, Erasmus JH, Tan Q, Nargi R, Soto C, Abbink P, Suscovich TJ, Durnell LA, Khandhar A, Archer J, Liang J, Fouch ME, Davidson E, Doranz BJ, Jones T, Larson E, Ertel S, Granger B, Fuerte-stone J, Roy V, Broge T, Linnekin TC, Linde CH, Gorman MJ, Nkolola J, Alter G, Reed SG, Barouch DH, Diamond MS, Crowe JE, Van Hoeven N, Thackray L, Carnahan R. Integrated technology platform for accelerated discovery of antiviral antibody therapeutics.. [DOI: 10.1101/2020.05.12.090944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 281 |
Al Harraq A, Lee JG, Bharti B. Magnetic field-driven assembly and reconfiguration of multicomponent supraparticles. Sci Adv 2020;6:eaba5337. [PMID: 32494727 DOI: 10.1126/sciadv.aba5337] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 282 |
de Taeye SW, Bentlage AEH, Mebius MM, Meesters JI, Lissenberg-Thunnissen S, Falck D, Sénard T, Salehi N, Wuhrer M, Schuurman J, Labrijn AF, Rispens T, Vidarsson G. FcγR Binding and ADCC Activity of Human IgG Allotypes. Front Immunol 2020;11:740. [PMID: 32435243 DOI: 10.3389/fimmu.2020.00740] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 17.7] [Reference Citation Analysis]
|
| 283 |
Cheng L, Cai Z, Ye T, Yu X, Chen Z, Yan Y, Qi J, Wang L, Liu Z, Cui W, Deng L. Injectable Polypeptide‐Protein Hydrogels for Promoting Infected Wound Healing. Adv Funct Mater 2020;30:2001196. [DOI: 10.1002/adfm.202001196] [Cited by in Crossref: 103] [Cited by in F6Publishing: 108] [Article Influence: 34.3] [Reference Citation Analysis]
|
| 284 |
Lambour J, Naranjo-gomez M, Boyer-clavel M, Pelegrin M. Differential and sequential immunomodulatory role of neutrophils and Ly6Chi inflammatory monocytes during antiviral antibody therapy.. [DOI: 10.1101/2020.04.22.055533] [Reference Citation Analysis]
|
| 285 |
Gardner MR. Promise and Progress of an HIV-1 Cure by Adeno-Associated Virus Vector Delivery of Anti-HIV-1 Biologics. Front Cell Infect Microbiol 2020;10:176. [PMID: 32391289 DOI: 10.3389/fcimb.2020.00176] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 286 |
Dimitrov JD, Lacroix-Desmazes S. Noncanonical Functions of Antibodies. Trends Immunol 2020;41:379-93. [PMID: 32273170 DOI: 10.1016/j.it.2020.03.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 287 |
Fox JM, Roy V, Gunn BM, Huang L, Edeling MA, Mack M, Fremont DH, Doranz BJ, Johnson S, Alter G, Diamond MS. Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes. Sci Immunol 2019;4:eaav5062. [PMID: 30796092 DOI: 10.1126/sciimmunol.aav5062] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 288 |
Giron LB, Papasavvas E, Azzoni L, Yin X, Anzurez A, Damra M, Mounzer K, Kostman JR, Sanne I, Firnhaber CS, Tateno H, Liu Q, Montaner LJ, Abdel-Mohsen M. Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint. AIDS 2020;34:681-6. [PMID: 31972605 DOI: 10.1097/QAD.0000000000002476] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 289 |
Langel SN, Otero CE, Martinez DR, Permar SR. Maternal gatekeepers: How maternal antibody Fc characteristics influence passive transfer and infant protection. PLoS Pathog 2020;16:e1008303. [PMID: 32214394 DOI: 10.1371/journal.ppat.1008303] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 290 |
Murray MJ, Bonilla-Medrano NI, Lee QL, Oxenford SJ, Angell R, Depledge DP, Reeves MB. Evasion of a Human Cytomegalovirus Entry Inhibitor with Potent Cysteine Reactivity Is Concomitant with the Utilization of a Heparan Sulfate Proteoglycan-Independent Route of Entry. J Virol 2020;94. [PMID: 31941787 DOI: 10.1128/JVI.02012-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 291 |
Ford-siltz LA, Wales S, Tohma K, Gao Y, Parra GI. Genotype-Specific Neutralization of Norovirus Is Mediated by Antibodies Against the Protruding Domain of the Major Capsid Protein. The Journal of Infectious Diseases 2020. [DOI: 10.1093/infdis/jiaa116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 292 |
Cao C, Yu L, Fu D, Yuan J, Liang X. Absolute quantitation of high abundant Fc-glycopeptides from human serum IgG-1. Analytica Chimica Acta 2020;1102:130-9. [DOI: 10.1016/j.aca.2019.12.035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 293 |
Xu J. SARS-CoV-2: an unknown agent and challenges in vaccine development. Journal of Bio-X Research 2020;3:3-5. [DOI: 10.1097/jbr.0000000000000063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 294 |
Gilchuk P, Murin CD, Milligan JC, Cross RW, Mire CE, Ilinykh PA, Huang K, Kuzmina N, Altman PX, Hui S, Gunn BM, Bryan AL, Davidson E, Doranz BJ, Turner HL, Alkutkar T, Flinko R, Orlandi C, Carnahan R, Nargi R, Bombardi RG, Vodzak ME, Li S, Okoli A, Ibeawuchi M, Ohiaeri B, Lewis GK, Alter G, Bukreyev A, Saphire EO, Geisbert TW, Ward AB, Crowe JE Jr. Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization. Immunity 2020;52:388-403.e12. [PMID: 32023489 DOI: 10.1016/j.immuni.2020.01.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 295 |
Saha A, Dixit NM. Pre-existing resistant proviruses can compromise maintenance of remission by VRC01 in chronic HIV-1 infection.. [DOI: 10.1101/2020.02.14.940395] [Reference Citation Analysis]
|
| 296 |
Idso MN, Akhade AS, Arrieta-Ortiz ML, Lai BT, Srinivas V, Hopkins JP Jr, Gomes AO, Subramanian N, Baliga N, Heath JR. Antibody-recruiting protein-catalyzed capture agents to combat antibiotic-resistant bacteria. Chem Sci 2020;11:3054-67. [PMID: 34122810 DOI: 10.1039/c9sc04842a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 297 |
Chen K, Magri G, Grasset EK, Cerutti A. Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA. Nat Rev Immunol 2020;20:427-41. [PMID: 32015473 DOI: 10.1038/s41577-019-0261-1] [Cited by in Crossref: 101] [Cited by in F6Publishing: 102] [Article Influence: 33.7] [Reference Citation Analysis]
|
| 298 |
Marques AC, Costa PJ, Velho S, Amaral MH. Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies. J Control Release 2020;320:180-200. [PMID: 31978444 DOI: 10.1016/j.jconrel.2020.01.035] [Cited by in Crossref: 85] [Cited by in F6Publishing: 93] [Article Influence: 28.3] [Reference Citation Analysis]
|
| 299 |
Pulendran B. Systems Biological Approaches for Mucosal Vaccine Development. Mucosal Vaccines 2020. [DOI: 10.1016/b978-0-12-811924-2.00045-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 300 |
Schmidt ME, Meyerholz DK, Varga SM. Pre-existing neutralizing antibodies prevent CD8 T cell-mediated immunopathology following respiratory syncytial virus infection. Mucosal Immunol 2020;13:507-17. [PMID: 31844172 DOI: 10.1038/s41385-019-0243-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 301 |
Hsu MN, Tay ZM, Lin WN, Wei S. Screening of Antigen-Specific Antibody-Secreting Cells. Handbook of Single Cell Technologies 2020. [DOI: 10.1007/978-981-10-4857-9_27-1] [Reference Citation Analysis]
|
| 302 |
Dufloo J, Guivel-Benhassine F, Buchrieser J, Lorin V, Grzelak L, Dupouy E, Mestrallet G, Bourdic K, Lambotte O, Mouquet H, Bruel T, Schwartz O. Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells. EMBO Rep 2020;21:e49351. [PMID: 31833228 DOI: 10.15252/embr.201949351] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 303 |
Zheng Q, Jiang J, He M, Zheng Z, Yu H, Li T, Xue W, Tang Z, Ying D, Li Z, Song S, Liu X, Wang K, Zhang Z, Wang D, Wang Y, Yan X, Zhao Q, Zhang J, Gu Y, Li S, Xia N. Viral neutralization by antibody-imposed physical disruption. Proc Natl Acad Sci U S A 2019:201916028. [PMID: 31818956 DOI: 10.1073/pnas.1916028116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 304 |
Fisher L, Zinter M, Stanfield-Oakley S, Carpp LN, Edwards RW, Denny T, Moodie Z, Laher F, Bekker LG, McElrath MJ, Gilbert PB, Corey L, Tomaras G, Pollara J, Ferrari G. Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells. Front Immunol 2019;10:2741. [PMID: 31827470 DOI: 10.3389/fimmu.2019.02741] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 305 |
Schmidt ST, Pedersen GK, Christensen D. Rational Design and In Vivo Characterization of Vaccine Adjuvants. ILAR J 2018;59:309-22. [PMID: 30624655 DOI: 10.1093/ilar/ily018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 306 |
Wang S, Xu M, Huang K, Zhi J, Sun C, Wang K, Zhou Q, Gao L, Jia Q, Shi H, An Z, Li P, Huang W. Biocompatible metal-free organic phosphorescent nanoparticles for efficiently multidrug-resistant bacteria eradication. Sci China Mater 2020;63:316-24. [DOI: 10.1007/s40843-019-1191-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 307 |
Maini MK, Burton AR. Restoring, releasing or replacing adaptive immunity in chronic hepatitis B. Nat Rev Gastroenterol Hepatol 2019;16:662-75. [PMID: 31548710 DOI: 10.1038/s41575-019-0196-9] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 308 |
Marqvorsen MHS, Araman C, van Kasteren SI. Going Native: Synthesis of Glycoproteins and Glycopeptides via Native Linkages To Study Glycan-Specific Roles in the Immune System. Bioconjug Chem 2019;30:2715-26. [PMID: 31580646 DOI: 10.1021/acs.bioconjchem.9b00588] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 309 |
Li SS, Gilbert PB, Carpp LN, Pyo CW, Janes H, Fong Y, Shen X, Neidich SD, Goodman D, deCamp A, Cohen KW, Ferrari G, Hammer SM, Sobieszczyk ME, Mulligan MJ, Buchbinder SP, Keefer MC, DeJesus E, Novak RM, Frank I, McElrath MJ, Tomaras GD, Geraghty DE, Peng X. Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial. J Virol 2019;93:e02041-18. [PMID: 31434737 DOI: 10.1128/JVI.02041-18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 310 |
Sedova ES, Scherbinin DN, Lysenko AA, Alekseeva SV, Artemova EA, Shmarov MM. Non-neutralizing Antibodies Directed at Conservative Influenza Antigens. Acta Naturae 2019;11:22-32. [PMID: 31993232 DOI: 10.32607/20758251-2019-11-4-22-32] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 311 |
McCarthy MK, Morrison TE. Blocking the Exit: CHIKV Neutralizing Antibodies Nip Viral Egress in the Bud. Cell Host Microbe 2018;24:328-30. [PMID: 30212644 DOI: 10.1016/j.chom.2018.08.008] [Reference Citation Analysis]
|
| 312 |
Labzin LI, Bottermann M, Rodriguez-Silvestre P, Foss S, Andersen JT, Vaysburd M, Clift D, James LC. Antibody and DNA sensing pathways converge to activate the inflammasome during primary human macrophage infection. EMBO J 2019;38:e101365. [PMID: 31468569 DOI: 10.15252/embj.2018101365] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 313 |
Burton DR. Antibody barriers to going viral. J Exp Med 2019;216:2226-8. [PMID: 31444247 DOI: 10.1084/jem.20191099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 314 |
Butler AL, Fallon JK, Alter G. A Sample-Sparing Multiplexed ADCP Assay. Front Immunol 2019;10:1851. [PMID: 31456799 DOI: 10.3389/fimmu.2019.01851] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 315 |
Godakova SA, Noskov AN, Vinogradova ID, Ugriumova GA, Solovyev AI, Esmagambetov IB, Tukhvatulin AI, Logunov DY, Naroditsky BS, Shcheblyakov DV, Gintsburg AL. Camelid VHHs Fused to Human Fc Fragments Provide Long Term Protection Against Botulinum Neurotoxin A in Mice. Toxins (Basel) 2019;11:E464. [PMID: 31394847 DOI: 10.3390/toxins11080464] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 316 |
Krueger CC, Thoms F, Keller E, Vogel M, Bachmann MF. Virus-Specific Secondary Plasma Cells Produce Elevated Levels of High-Avidity Antibodies but Are Functionally Short Lived. Front Immunol 2019;10:1831. [PMID: 31447844 DOI: 10.3389/fimmu.2019.01831] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 317 |
Dovgan I, Koniev O, Kolodych S, Wagner A. Antibody-Oligonucleotide Conjugates as Therapeutic, Imaging, and Detection Agents. Bioconjug Chem 2019;30:2483-501. [PMID: 31339691 DOI: 10.1021/acs.bioconjchem.9b00306] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 318 |
Fischinger S, Fallon JK, Michell AR, Broge T, Suscovich TJ, Streeck H, Alter G. A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation. J Immunol Methods 2019;473:112630. [PMID: 31301278 DOI: 10.1016/j.jim.2019.07.002] [Cited by in Crossref: 90] [Cited by in F6Publishing: 71] [Article Influence: 22.5] [Reference Citation Analysis]
|
| 319 |
Tesfaye DY, Gudjonsson A, Bogen B, Fossum E. Targeting Conventional Dendritic Cells to Fine-Tune Antibody Responses. Front Immunol 2019;10:1529. [PMID: 31333661 DOI: 10.3389/fimmu.2019.01529] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 320 |
Widjaja I, Wang C, van Haperen R, Gutiérrez-Álvarez J, van Dieren B, Okba NMA, Raj VS, Li W, Fernandez-Delgado R, Grosveld F, van Kuppeveld FJM, Haagmans BL, Enjuanes L, Drabek D, Bosch BJ. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein. Emerg Microbes Infect 2019;8:516-30. [PMID: 30938227 DOI: 10.1080/22221751.2019.1597644] [Cited by in Crossref: 88] [Cited by in F6Publishing: 73] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 321 |
Weber SS, Stoycheva D, Nimmerjahn F, Oxenius A. Two sequential layers of antibody-mediated control of Legionella pneumophila infection. Eur J Immunol 2019;49:1415-20. [PMID: 31074841 DOI: 10.1002/eji.201948106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 322 |
Maibom-Thomsen SL, Trier NH, Holm BE, Hansen KB, Rasmussen MI, Chailyan A, Marcatili P, Højrup P, Houen G. Immunoglobulin G structure and rheumatoid factor epitopes. PLoS One 2019;14:e0217624. [PMID: 31199818 DOI: 10.1371/journal.pone.0217624] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 323 |
Goulet DR, Atkins WM. Considerations for the Design of Antibody-Based Therapeutics. J Pharm Sci 2020;109:74-103. [PMID: 31173761 DOI: 10.1016/j.xphs.2019.05.031] [Cited by in Crossref: 76] [Cited by in F6Publishing: 83] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 324 |
Wilson RP, McGettigan SE, Dang VD, Kumar A, Cancro MP, Nikbakht N, Stohl W, Debes GF. IgM Plasma Cells Reside in Healthy Skin and Accumulate with Chronic Inflammation. J Invest Dermatol 2019;139:2477-87. [PMID: 31152755 DOI: 10.1016/j.jid.2019.05.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 325 |
McMichael EL, Benner B, Atwal LS, Courtney NB, Mo X, Davis ME, Campbell AR, Duggan MC, Williams K, Martin K, Levine K, Olaverria Salavaggione GN, Noel T, Ganju A, Uppati S, Paul B, Olencki T, Teknos TN, Savvides P, Tridandapani S, Byrd JC, Caligiuri MA, Liu SV, Carson WE 3rd. A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 2019;25:4955-65. [PMID: 31142501 DOI: 10.1158/1078-0432.CCR-18-2108] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 326 |
Vonarburg C, Loetscher M, Spycher MO, Kropf A, Illi M, Salmon S, Roberts S, Steinfuehrer K, Campbell I, Koernig S, Bain J, Edler M, Baumann U, Miescher S, Metzger DW, Schaub A, Käsermann F, Zuercher AW. Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates. Respir Res 2019;20:99. [PMID: 31118031 DOI: 10.1186/s12931-019-1057-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 327 |
Yang C, Gong R, de Val N. Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein Structure. Virol Sin 2019;34:168-74. [PMID: 31020573 DOI: 10.1007/s12250-019-00093-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 328 |
Berger M. Antibodies to vaccine antigens in pooled polyclonal human IgG products. Transfusion 2018;58 Suppl 3:3096-105. [PMID: 30536430 DOI: 10.1111/trf.15017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 329 |
Hess AS, Lunney JK, Abrams S, Choi I, Trible BR, Hess MK, Rowland RRR, Plastow GS, Dekkers JCM. Identification of factors associated with virus level in tonsils of pigs experimentally infected with porcine reproductive and respiratory syndrome virus. J Anim Sci 2019;97:536-47. [PMID: 30496411 DOI: 10.1093/jas/sky446] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 330 |
Schiller JL, Marvin A, McCallen JD, Lai SK. Robust antigen-specific tuning of the nanoscale barrier properties of biogels using matrix-associating IgG and IgM antibodies. Acta Biomater 2019;89:95-103. [PMID: 30878451 DOI: 10.1016/j.actbio.2019.03.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 331 |
Borenstein-Katz A, Shulman A, Hamawi H, Leitner O, Diskin R. Differential Antibody-Based Immune Response against Isolated GP1 Receptor-Binding Domains from Lassa and Junín Viruses. J Virol 2019;93:e00090-19. [PMID: 30728269 DOI: 10.1128/JVI.00090-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 332 |
Sintou A, Rifai SE, Mansfield C, Sanchez Alonso JL, Rothery SM, Narodden S, Sharma K, Hasham MG, Swiatlowska P, Harding SE, Rosenthal N, Gorelik J, Sattler S. Persistent anti-heart autoimmunity causes cardiomyocyte damage in chronic heart failure.. [DOI: 10.1101/542597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 333 |
Patel KR, Roberts JT, Barb AW. Multiple Variables at the Leukocyte Cell Surface Impact Fc γ Receptor-Dependent Mechanisms. Front Immunol 2019;10:223. [PMID: 30837990 DOI: 10.3389/fimmu.2019.00223] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 334 |
Desikan R, Raja R, Dixit NM. Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection.. [DOI: 10.1101/548727] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 335 |
Alter G, Barouch D. Immune Correlate-Guided HIV Vaccine Design. Cell Host Microbe 2018;24:25-33. [PMID: 30001521 DOI: 10.1016/j.chom.2018.06.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 336 |
Kanyavuz A, Marey-jarossay A, Lacroix-desmazes S, Dimitrov JD. Breaking the law: unconventional strategies for antibody diversification. Nat Rev Immunol 2019;19:355-68. [DOI: 10.1038/s41577-019-0126-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 337 |
Greiner V, Bou Puerto R, Liu S, Herbel C, Carmona EM, Goldberg MS. CRISPR-Mediated Editing of the B Cell Receptor in Primary Human B Cells. iScience 2019;12:369-78. [PMID: 30769282 DOI: 10.1016/j.isci.2019.01.032] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 338 |
Husain B, Ellerman D. Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies. BioDrugs 2018;32:441-64. [PMID: 30132211 DOI: 10.1007/s40259-018-0299-9] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 339 |
Karch CP, Matyas GR, Burkhard P, Beck Z. Glycosylation of the HIV-1 Env V1V2 loop to form a native-like structure may not be essential with a nanoparticle vaccine. Future Virol 2019;14:51-4. [PMID: 30815025 DOI: 10.2217/fvl-2018-0174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 340 |
Mantis NJ. Role of B Cells and Antibodies in Controlling Bacterial Pathogens. Reference Module in Biomedical Sciences 2019. [DOI: 10.1016/b978-0-12-801238-3.66120-2] [Reference Citation Analysis]
|
| 341 |
Vogt MR, Crowe JE Jr. Current Understanding of Humoral Immunity to Enterovirus D68. J Pediatric Infect Dis Soc 2018;7:S49-53. [PMID: 30590621 DOI: 10.1093/jpids/piy124] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 342 |
Liechti T, Roederer M. OMIP-051 - 28-color flow cytometry panel to characterize B cells and myeloid cells. Cytometry A 2019;95:150-5. [PMID: 30549419 DOI: 10.1002/cyto.a.23689] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 343 |
Welles HC, Jennewein MF, Mason RD, Narpala S, Wang L, Cheng C, Zhang Y, Todd JP, Lifson JD, Balazs AB, Alter G, McDermott AB, Mascola JR, Roederer M. Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge. PLoS Pathog 2018;14:e1007395. [PMID: 30517201 DOI: 10.1371/journal.ppat.1007395] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 344 |
Abreu R, Ross TM. Influenza – A new pathogen every year. Current Opinion in Systems Biology 2018;12:12-21. [DOI: 10.1016/j.coisb.2018.08.011] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 345 |
Zhou Y, Chen C, Chen Y, Liu Z, Zheng J, Wang T, Luo H, Liu Y, Shan Y, Fang W, Li X. Effect of route of inoculation on innate and adaptive immune responses to porcine epidemic diarrhea virus infection in suckling pigs. Vet Microbiol 2019;228:83-92. [PMID: 30593385 DOI: 10.1016/j.vetmic.2018.11.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 346 |
Raeven RHM, van Riet E, Meiring HD, Metz B, Kersten GFA. Systems vaccinology and big data in the vaccine development chain. Immunology. 2019;156:33-46. [PMID: 30317555 DOI: 10.1111/imm.13012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 347 |
Falach R, Sapoznikov A, Alcalay R, Aftalion M, Ehrlich S, Makovitzki A, Agami A, Mimran A, Rosner A, Sabo T, Kronman C, Gal Y. Generation of Highly Efficient Equine-Derived Antibodies for Post-Exposure Treatment of Ricin Intoxications by Vaccination with Monomerized Ricin. Toxins (Basel) 2018;10:E466. [PMID: 30424519 DOI: 10.3390/toxins10110466] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 348 |
Ganchua SKC, Cadena AM, Maiello P, Gideon HP, Myers AJ, Junecko BF, Klein EC, Lin PL, Mattila JT, Flynn JL. Lymph nodes are sites of prolonged bacterial persistence during Mycobacterium tuberculosis infection in macaques. PLoS Pathog 2018;14:e1007337. [PMID: 30383808 DOI: 10.1371/journal.ppat.1007337] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 349 |
Tkaczyk C, Semenova E, Shi YY, Rosenthal K, Oganesyan V, Warrener P, Stover CK, Sellman BR. Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity In Vitro and Staphylococcus aureus Fitness in Infection Models. Antimicrob Agents Chemother 2018;62:e01033-18. [PMID: 30150481 DOI: 10.1128/AAC.01033-18] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 350 |
Saphire EO, Schendel SL, Gunn BM, Milligan JC, Alter G. Antibody-mediated protection against Ebola virus. Nat Immunol 2018;19:1169-78. [PMID: 30333617 DOI: 10.1038/s41590-018-0233-9] [Cited by in Crossref: 103] [Cited by in F6Publishing: 102] [Article Influence: 20.6] [Reference Citation Analysis]
|
| 351 |
Lambert C, Couteaudier M, Gouzil J, Richard L, Montange T, Betsem E, Rua R, Tobaly-Tapiero J, Lindemann D, Njouom R, Mouinga-Ondémé A, Gessain A, Buseyne F. Potent neutralizing antibodies in humans infected with zoonotic simian foamy viruses target conserved epitopes located in the dimorphic domain of the surface envelope protein. PLoS Pathog 2018;14:e1007293. [PMID: 30296302 DOI: 10.1371/journal.ppat.1007293] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 352 |
Yermanos AD, Dounas AK, Stadler T, Oxenius A, Reddy ST. Tracing Antibody Repertoire Evolution by Systems Phylogeny. Front Immunol 2018;9:2149. [PMID: 30333820 DOI: 10.3389/fimmu.2018.02149] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 353 |
Shan M, Carrillo J, Yeste A, Gutzeit C, Segura-Garzón D, Walland AC, Pybus M, Grasset EK, Yeiser JR, Matthews DB, van de Veen W, Comerma L, He B, Boonpiyathad T, Lee H, Blanco J, Osborne LC, Siracusa MC, Akdis M, Artis D, Mehandru S, Sampson HA, Berin MC, Chen K, Cerutti A. Secreted IgD Amplifies Humoral T Helper 2 Cell Responses by Binding Basophils via Galectin-9 and CD44. Immunity 2018;49:709-724.e8. [PMID: 30291028 DOI: 10.1016/j.immuni.2018.08.013] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 354 |
Nelson CS, Herold BC, Permar SR. A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection. NPJ Vaccines 2018;3:38. [PMID: 30275984 DOI: 10.1038/s41541-018-0074-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 355 |
Coler RN, Day TA, Ellis R, Piazza FM, Beckmann AM, Vergara J, Rolf T, Lu L, Alter G, Hokey D, Jayashankar L, Walker R, Snowden MA, Evans T, Ginsberg A, Reed SG; TBVPX-113 Study Team. The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial. NPJ Vaccines 2018;3:34. [PMID: 30210819 DOI: 10.1038/s41541-018-0057-5] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 17.6] [Reference Citation Analysis]
|
| 356 |
Sicca F, Neppelenbroek S, Huckriede A. Effector mechanisms of influenza-specific antibodies: neutralization and beyond. Expert Rev Vaccines 2018;17:785-95. [PMID: 30145912 DOI: 10.1080/14760584.2018.1516553] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 357 |
Gilchuk P, Kuzmina N, Ilinykh PA, Huang K, Gunn BM, Bryan A, Davidson E, Doranz BJ, Turner HL, Fusco ML, Bramble MS, Hoff NA, Binshtein E, Kose N, Flyak AI, Flinko R, Orlandi C, Carnahan R, Parrish EH, Sevy AM, Bombardi RG, Singh PK, Mukadi P, Muyembe-Tamfum JJ, Ohi MD, Saphire EO, Lewis GK, Alter G, Ward AB, Rimoin AW, Bukreyev A, Crowe JE Jr. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity 2018;49:363-374.e10. [PMID: 30029854 DOI: 10.1016/j.immuni.2018.06.018] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 10.2] [Reference Citation Analysis]
|
| 358 |
Burton AR, Pallett LJ, McCoy LE, Suveizdyte K, Amin OE, Swadling L, Alberts E, Davidson BR, Kennedy PT, Gill US, Mauri C, Blair PA, Pelletier N, Maini MK. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603. [PMID: 30091725 DOI: 10.1172/jci121960] [Cited by in Crossref: 145] [Cited by in F6Publishing: 156] [Article Influence: 29.0] [Reference Citation Analysis]
|
| 359 |
Dufloo J, Bruel T, Schwartz O. HIV-1 cell-to-cell transmission and broadly neutralizing antibodies. Retrovirology 2018;15:51. [PMID: 30055632 DOI: 10.1186/s12977-018-0434-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 360 |
Subbaraman H, Schanz M, Trkola A. Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy? Retrovirology 2018;15:52. [PMID: 30055627 DOI: 10.1186/s12977-018-0433-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 361 |
Paul A, Padler-Karavani V. Evolution of sialic acids: Implications in xenotransplant biology. Xenotransplantation 2018;25:e12424. [PMID: 29932472 DOI: 10.1111/xen.12424] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 362 |
Baraniak I, Kropff B, Ambrose L, McIntosh M, McLean GR, Pichon S, Atkinson C, Milne RSB, Mach M, Griffiths PD, Reeves MB. Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies. Proc Natl Acad Sci U S A 2018;115:6273-8. [PMID: 29686064 DOI: 10.1073/pnas.1800224115] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 363 |
Haakenson JK, Huang R, Smider VV. Diversity in the Cow Ultralong CDR H3 Antibody Repertoire. Front Immunol 2018;9:1262. [PMID: 29915599 DOI: 10.3389/fimmu.2018.01262] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 364 |
Tkaczyk C, Semenova E, Shi Y, Rosenthal K, Oganesyan V, Warrener P, Stover C, Sellman B. Alanine scanning mutagenesis of the MEDI4839 (Suvratoxumab) epitope reduces alpha toxin lytic activity in vitro and S. aureus fitness in infection models.. [DOI: 10.1101/323642] [Reference Citation Analysis]
|
| 365 |
Clark LE, Mahmutovic S, Raymond DD, Dilanyan T, Koma T, Manning JT, Shankar S, Levis SC, Briggiler AM, Enria DA, Wucherpfennig KW, Paessler S, Abraham J. Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses. Nat Commun 2018;9:1884. [PMID: 29760382 DOI: 10.1038/s41467-018-04271-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 366 |
Lilienthal GM, Rahmöller J, Petry J, Bartsch YC, Leliavski A, Ehlers M. Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways. Front Immunol 2018;9:958. [PMID: 29867943 DOI: 10.3389/fimmu.2018.00958] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 367 |
Turula H, Wobus CE. The Role of the Polymeric Immunoglobulin Receptor and Secretory Immunoglobulins during Mucosal Infection and Immunity. Viruses 2018;10:E237. [PMID: 29751532 DOI: 10.3390/v10050237] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 16.4] [Reference Citation Analysis]
|
| 368 |
Nally JE, Wilson-Welder JH, Hornsby RL, Palmer MV, Alt DP. Inbred Rats as a Model to Study Persistent Renal Leptospirosis and Associated Cellular Immune Responsiveness. Front Cell Infect Microbiol 2018;8:66. [PMID: 29594063 DOI: 10.3389/fcimb.2018.00066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 369 |
Kuka M, Iannacone M. Viral subversion of B cell responses within secondary lymphoid organs. Nat Rev Immunol 2018;18:255-65. [PMID: 29249807 DOI: 10.1038/nri.2017.133] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 370 |
[DOI: 10.1101/2021.02.06.430072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
